80
October 27–30, 2016 Hilton Chicago Chicago, Illinois USA asdp.org/AM16 53 rd Annual Meeting ASDP #ASDP2016 @ASDPTweets

ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Embed Size (px)

Citation preview

Page 1: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

October 27–30, 2016Hilton Chicago

Chicago, Illinois USA

asdp.org/AM16

53rd Annual MeetingASDP

#ASDP2016@ASDPTweets

Page 2: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The majority of melanoma patients are diagnosed with early stage disease1

The majority of deaths due tomelanoma occur among those patients initially diagnosed as Stage I or II 2,3

A patient’s tumor biology can provide individual risk information beyond traditional clinical factors

DecisionDx®-Melanoma is a molecular diagnostic test utilizing tumor biology to provide an individual risk of melanoma

recurrence beyond traditional factors.4-6

Call us at 866.788.9007 or visit www.SkinMelanoma.com

1. SEER Stat Fact Sheets: Melanoma of the Skin. Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/statfacts/html/melan.html. Accessed August 1, 2016.

2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206.3. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med

2014;370:599-609.4. Gerami P, Cook RW, Wilkinson J, et al. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous

melanoma. Clin Cancer Res 2015;21:175-83.5. Gerami P, Cook RW, Russell MC, et al. Gene expression profiling for molecular staging of cutaneous melanoma in patients with sentinel lymph

node biopsy. J Am Acad Dermatol 2015;72:780-785.6. Zager JS, Messina J, Sondak VK, et al. Performance of a 31-gene expression profile in a previously unreported cohort of 334 cutaneous

melanoma patients. J Clin Oncol 2016;34 (suppl; abstr 9581).

©Castle Biosciences, Inc. 2016CM018-1609v1www.CastleBiosciences.com

Page 3: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

PORTECOCHERE

4

SERVICE AREASERVICE AREA

A B C

CONTINENTAL BALLROOM

FOYER

SER

VICE

CO

RR

IDO

R

COAT

CH

ECK/

8TH

ST.

N

8TH

ST.

S.

REG

.

SNAX

KITTY O’SHEA’S ENTRANCE FOYERGRAND

TRADITION720 SOUTH BAR

GUEST CHECK-IN

GREAT HALLGIFTSHOP

SOUTHOFFICE

NORTHOFFICE

PO

HS TFIG

SSENIS

UBRET

NEC

ESCALATORS TOLOWER LEVEL

GIFTSHOP

ESCALATORS TOSW EXHIBIT HALL

BUCKINGHAMROOM

OFF

ICE

8TH ST.W.

OFFICE

STREET ENTRANCE

720 SOUTHGRILL

ADAELEVATOR

STAIRS TO 3RD FLOORADA ELEVATOR

ADALIFT

The majority of melanoma patients are diagnosed with early stage disease1

The majority of deaths due tomelanoma occur among those patients initially diagnosed as Stage I or II 2,3

A patient’s tumor biology can provide individual risk information beyond traditional clinical factors

DecisionDx®-Melanoma is a molecular diagnostic test utilizing tumor biology to provide an individual risk of melanoma

recurrence beyond traditional factors.4-6

Call us at 866.788.9007 or visit www.SkinMelanoma.com

1. SEER Stat Fact Sheets: Melanoma of the Skin. Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/statfacts/html/melan.html. Accessed August 1, 2016.

2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206.3. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med

2014;370:599-609.4. Gerami P, Cook RW, Wilkinson J, et al. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous

melanoma. Clin Cancer Res 2015;21:175-83.5. Gerami P, Cook RW, Russell MC, et al. Gene expression profiling for molecular staging of cutaneous melanoma in patients with sentinel lymph

node biopsy. J Am Acad Dermatol 2015;72:780-785.6. Zager JS, Messina J, Sondak VK, et al. Performance of a 31-gene expression profile in a previously unreported cohort of 334 cutaneous

melanoma patients. J Clin Oncol 2016;34 (suppl; abstr 9581).

©Castle Biosciences, Inc. 2016CM018-1609v1www.CastleBiosciences.com

Lobby Level

Hilton Chicago

ASDP Art Show /

Dermatopathology Bookstore

Registration

Speaker Ready Room

Posters/ ASDP Career

Center

Page 4: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Hilton Chicago

Evening Slide Symposium/ Helwig Lecture/President’s Address

Self-Assessment Discussion

President’s Banquet/Membership Business Meeeting and Luncheon

Duel in Dermatopathology/ Basic Science Course/ Mini Course/Short Courses/Oral Abstract Sessions/

Future Directions in Dermatopathology/ Fellows’ Presentations

Self-Assesment in Dermatopathology/

Slide Library

Evening Slide Symposium Preview

Breakfast/Young Physicians’ Reception

Consultations in Dermatopathology

Second Floor

Third Floor6

INTERNATIONAL BALLROOM

SOUTH NORTH

DRESSING ROOM

INTERNATIONAL FOYER

GRAND BALLROOM

NORMANDIE LOUNGE

A

BOULEVARDFOYER

B

BOULEVARD ROOMS

CGR

AN

D F

OY

ER

COAT CHECK SERVICE

ADALIFT

Please note that the International Ballroom and Foyer are accessedthrough the Lobby Level.

ADAELEVATOR

STAIRS TO 3RD FLOOR

SERVICE

8

JOL

IET

RO

OM

MA

RQ

UE

TT

ER

OO

M

JOL

IET

FO

YE

R

PD

R 7

PD

R 6

PD

R 5

ASTORIAROOM

WALDORFROOM

A B C

WILLIFORD ROOMS

PDR 3

PDR 4

CO

AT

C

HE

CK

PDR 2

PDR 1

MA

RQ

UE

TTE

F

OY

ER

SVC. AREA

SERVICE AREASERVICE AREA

STAIRS TOINTERNATIONAL BALLROOM

Page 5: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Meeting Program

#ASDP2016 www.asdp.org/AM16 5

Gene

ral

Info

rmat

ion

Table of ContentsGeneral Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Faculty Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12 2016 Founders’ and Nickel Award Recipients . . . . . . . . . . . . . . . . . . . . .15 Committee Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16 Corporate Partners, Sponsors and Advertisers . . . . . . . . . . . . . . . . . . . .17Program-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 Plenary Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Thursday, October 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25 Friday, October 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34 Saturday, October 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40 Sunday, October 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52Optional Courses & Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 Consultations in Dermatopathology . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56 Mini Course – Alopecia: Step-by-Step . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Self-Assessment in Dermatopathology . . . . . . . . . . . . . . . . . . . . . . . . . . .62 President’s Reception & Banquet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Meet the Program Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66CME Attendance Log . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67Index of Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77

2016 Program CommitteeSteven D. Billings, MD, Chair Cleveland Clinic

Ronald P. Rapini, MD University of Texas Medical School and the University of Texas MD Anderson Cancer Center

Tammie C. Ferringer, MD Geisinger Medical Center

Beth S. Ruben, MD Palo Alto Medical Foundation

Melissa Pulitzer, MD Memorial Sloan Kettering Cancer Center

Raymond L. Barnhill, MD, Ad Hoc Institut Curie and University of Paris Descartes

Satu

rday

, O

ctob

er 2

9Su

nday

, O

ctob

er 3

0O

ptio

nal C

ours

es

& Ev

ents

Inde

x of F

acul

tyGe

nera

l In

form

atio

nPr

ogra

m-a

t-a-

Glan

ceTh

ursd

ay,

Oct

ober

27

Frid

ay,

Oct

ober

28

Self-Assesment in Dermatopathology/

Slide Library

Evening Slide Symposium Preview

Consultations in Dermatopathology

Page 6: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

6 www.asdp.org/AM16 #ASDP2016

General InformationContinuing Medical EducationThe American Society of Dermatopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians . The American Society of Dermatopathology designates this live activity for a maximum of 35 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity .

The American Society of Dermatopathology Annual Meeting, Program #254100, is recog-nized by the American Academy of Dermatology for 35 AAD Recognized Credits and may be used toward the AAD CME Award .

Continuing Medical Education PolicyThe American Society of Dermatopathology (ASDP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) . As such, we are required to meet the ACCME’s expectations for our practice of continuing medical education .

It is the policy of the ASDP to ensure balance, independence, objectivity and scientific rigor in all of its educational activities . Faculty participating in and planning the Annual Meeting must comply with all procedures governing disclosure . The ASDP has imple-mented a process where everyone in a position to control the content of an educational activity will present evidence-based content, disclose all relevant financial relationships with any commercial interest and discussion of unlabeled/investigational uses of a commercial product . In addition, presentations must be free of commercial bias and any information regarding commercial products/services must be based on scientific meth-ods generally accepted by the medical community. Conflicts were resolved prior to this educational activity. Faculty who refused to disclose relevant financial relationships and discussion of unlabeled/investigational uses of a commercial product would have been disqualified from being a part of the planning and implementation of this CME activity.

Presenters who qualified for the implementation of this activity are required to disclose to the audience verbally and in writing, immediately prior to the scientific presentation, any of the relationships mentioned above . Faculty relationships are also disclosed to audiences in this program book .

Page 7: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 7

Gene

ral

Info

rmat

ion

CME Claims and Verification of AttendanceImportant! Attendees will be able to claim their CME credits online via the ASDP website after the meeting. You must submit your CME credit online in order to receive appropriate CME credit . The number of CME credit available for each course is indicated by the course title in this program, in the CME Attendance Log and on the online CME submission site . The CME Attendance Log is included in this book on page 67. An official CME certificate will be available to print immediately after completing the online CME claim form and evaluation. Paper certificates will not be mailed.

Appropriate credit for attendance should be ascertained and reported by individual physicians to the particular state or medical society to which he/she belongs . For those registered in the AAD CME Transcript/Award Program, you should log in to the AAD Online CME Transcript Program to enter credits for this AAD Recognized program . ASDP’s AAD program number is 254100 .

MOC Claims and VerificationMOC credit for the Self-Assessment in Dermatopathology sessions will not be included on the Annual Meeting CME Certificates. Participants must complete the post-course online self-assessment with a score of 60 percent or better in order to claim MOC credit for Self-Assessment in Dermatopathology. A MOC certificate will be available to print upon successful completion of the post-course online self-assessment .

The American Board of Dermatology has expanded options for diplomates to obtain MOC self-assessment credits to include live sessions integrating audience response system (ARS) questions . As a result, this year’s Evening Slide Symposium and Short Course I are now eligible for MOC Component II: Lifelong Learning and Self-Assessment credit .

Learning ObjectivesThe educational mission of the American Society of Dermatopathology is to teach, aid in the dissemination of knowledge and encourage research to improve the quality of the practice of dermatopathology . The annual meeting is primarily an educational one, offering members, fellows, residents and medical students lectures on current topics in dermatopathology, interactive sessions at the microscope, a self-assessment course, and opportunities for poster and abstract presentations .

After attending the 2016 Annual Meeting, participants should be able to: ➜ Show improved overall diagnostic skills in dermatopathology following exposure to

clinical and histopathological aspects of a broad range of dermatologic diseases .

➜ Develop and apply a cost-effective approach to the use of ancillary tests, including immunohistochemistry and molecular techniques in dermatopathologic diagnoses .

➜ Describe recent advances in the diagnosis of melanocytic tumors and their impact on the practice of dermatopathology .

Page 8: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

8 www.asdp.org/AM16 #ASDP2016

➜ Enhance patient care by diagnosing a wide range of challenging areas of derma-topathology, such as the pathology of the nail and cutaneous lymphoproliferative disorders and developing a practical approach to handling such cases .

➜ Outline new scientific dermatopathologic endeavors and discoveries, conveyed by colleagues involved in research .

➜ Understand how complex interactions of genetics, immune system and environment play a role in dermatopathologic diseases .

➜ Demonstrate an approach toward diagnosis of various challenging skin biopsies and generate relevant differential diagnoses.

➜ Identify and overcome challenges faced in the early stages of both private practice and academic dermatopathology careers .

➜ Apply appropriate tools and skill sets to support decision making and ease legal concerns at various career stages .

ACGME CompetenciesThe ASDP 53rd Annual Meeting is designed to meet the following Accreditation Council of Graduate Medical Education competencies:

➜ Medical Knowledge

➜ Patient Care

➜ Practice-based Learning and Improvement

➜ Quality Improvement

➜ Employ Evidence-based Practice

➜ Systems-based Practice

Learning Objectives (continued)

Page 9: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 9

Gene

ral

Info

rmat

ion

Poster PresentationsContinental Ballroom, Lobby Level1.5 AMA PRA Category 1 CreditTM 1.5 AAD Recognized Credit

Participants will earn .75 AMA PRA Category 1 CME Credit™ for each Poster Defense Session attended .

Basic research, practical techniques and new clinical or histopathologic entities will be presented in this traditional and popular format . Posters will be on display in two poster sessions Thursday afternoon through Sunday morning. Residents and fellows-in-training are eligible for the ASDP Physician-in-Training Awards . Awards will be presented on Sunday morning, 8:30 a .m . – 8:45 a .m ., immediately before Short Course IV . See the Program-at-a-Glance for complete Poster Session 1 and 2 schedules .

Poster viewing opens at 1 p.m. Thursday, October 27, and closes at 11 a.m. Sunday, October 30.

Poster Defense SessionsThe poster defense sessions will provide an opportunity for discussion between poster presenters and attendees. Poster presenters are asked to make every effort to be at their poster during the defense sessions .

Poster Session 1 Defense:Friday, October 28: 4:15 p .m . – 5:00 p .m .

Poster Session 2 Defense:Saturday, October 29: 10:00 a .m . – 10:45 a .m .

After attending the Poster Defense Sessions, participants should be able to:

➜ Identify practical techniques in dermatopathology .

➜ Name new clinical or histopathological entities .

What’s the Buzz?ASDP Social Media Buzz Award Most tweets from the meeting wins a $50 Amazon gift card!Include #ASDP2016 in your tweets to qualify.

Details at asdp.org/am16.@ASDPTweets

Page 10: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

10 www.asdp.org/AM16 #ASDP2016

Slide LibraryOpens Friday, October 28, at 1 p.m.Williford B/C, 3rd Floor

The ASDP Slide Library opens Friday, October 28, at 1 p .m . and will be open 24-hours-a-day through Sunday, October 30, at 11 a .m .

Selected cases from the continuously growing slide library will be available for micro-scopic examination . Cases are accompanied by the diagnoses and other relevant written information and references . The 2016 Slide Library handout with case summaries, diagnoses with discussion and references will be available to download from the online handout page at www .asdp .org/AM16Handouts .

Upon completion of study, participants should be able to: ➜ Explain histologic diagnoses of various skin conditions, including the use of ancillary

studies, where appropriate .

➜ Interpret histologic diagnoses of uncommon skin diseases .

➜ Critique cases that highlight diagnostic challenges .

➜ Apply morphological criteria to differential diagnoses of cutaneous lesions.

➜ Develop appropriate differential diagnoses for a wide spectrum of tumors and dermatoses .

Membership Business MeetingSaturday, October 2912:30 p.m. – 1:45 p.m.International Ballroom South, 2nd Floor

ASDP members should attend the Membership Business Meeting luncheon on Saturday, October 29 . The annual report to the membership will be distributed to each meeting participant .

Page 11: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 11

Gene

ral

Info

rmat

ion

Evening Slide Symposium PreviewOpens Thursday, October 27, at 8 a.m.PDR #4, 3rd Floor

The Evening Slide Symposium Preview opens Thursday, October 27, at 8 a .m ., and will be open 24-hours-a-day through Sunday, October 30, at 11 a .m .

Preview the Evening Slide Symposium cases at any time during the annual meeting and attend the Evening Slide Symposium Saturday evening .

ASDP Career CenterContinental Ballroom, Lobby Level

The official ASDP career center is located on the website at www.asdp.org; however, the Society has employment boards located in the Continental Ballroom on the Lobby Level . Meeting registrants can post positions available or resumes for other attendees to peruse . Meeting attendees are responsible for making their own copies .

Dermatopathology BookstoreWednesday, October 26 – Sunday, October 30Continental Ballroom Foyer, Lobby Level

Leading publishers in the field of dermatopathology will be selling books and other pub-lications during the ASDP 53rd Annual Meeting . Be sure to stop by and view the newest work being published! The Dermatopathology Bookstore will be open during registration hours, in the Continental Ballroom Foyer, Lobby Level .

Participating book sellers include:ElsevierWolters Kluwer

Page 12: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

12 www.asdp.org/AM16 #ASDP2016

Faculty Disclosures of Relevant Financial RelationshipsIn keeping with ACCME standards, the following program faculty stated that they do not have relevant financial relationships that may have a direct bearing on the subject matter of the continuing education activity in which they are participating .

Liaqat Ali, MDJosette André, MDZsolt B . Argenyi, MDPhyu Aung, MD, PhD, FACPArmita Bahrami, MDRaymond L . Barnhill, MDBoris C . Bastian, MDSteven D . Billings, MDAlina G . Bridges, DONooshin K . Brinster, MDKlaus J . Busam, MDDavid S . Cassarino, MD, PhDClay J . Cockerell, MDLynn D . Cooper, MDShawn E . Cowper, MDApril C . Deng, MDDavid J . DiCaudo, MDLyn M . Duncan, MDKojo Elenitoba-Johnson, MDDirk M . Elston, MD Patrick O . Emanuel, MBChB, Dip ArtsTammie C . Ferringer, MDJerad M . Gardner, MDLoren E . Golitz, MDJoan Guitart, MDJiali Han, PhDMai P . Hoang, MDDiona Ivan, MDElaine K . Jeter, MDRichard C . Jordan, DDS, PhD, FRCPathHideko Kamino, MDLaszlo J . Karai, MD, PhDWerner Kempf, MDJinah Kim, MD, PhDEleanor A . Knopp, MDJennifer S . Ko, MDCarrie L . Kovarik, MD

Jessica A . Kozel, MD, FASDPPhilip E . LeBoit, MDChristine G . Lian, MDBrandon Litzner, MDVincent Lui, MDLori Lowe, MDTimothy H . McCalmont, MDDaniel D . Miller, MDAnisha B . Patel, MDRajiv M . Patel, MDSara B . Peters, MDVesna Petronic-Rosic, MD, MSc Michael W . Piepkorn, MD, PhDLaura B . Pincus, MDMelissa Pulitzer, MDMichael S . Rabkin, MD, PhDRonald P . Rapini, MD Kerri E . Rieger, MD, PhDLeslie Robinson-Bostom, MDAlistair M . Robson, MDBeth S . Ruben, MDAdam I . Rubin, MDOmar P . Sangueza, MDM . Angelica Selim, MDSara Shalin, MD, PhDLeonard C . Sperling, MDCatherine M . Stefanato, MD, FRCPathAntonio Subtil, MD, MBAUma N . Sundram, MD, PhDCurtis T . Thompson, MDCarlos Torres-Cabala, MDThomas White, MDArtur Zembowicz, MD, PhD

Page 13: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 13

Gene

ral

Info

rmat

ion

Faculty Disclosures or Relevant Financial Relationships (continued)The program faculty listed below disclosed information about their financial interests. The ASDP Ethics Committee has reviewed these disclosures and determined that no real conflicts of interest exist between financial relationships and educational content being presented:

Faculty Company Affiliation/Relationship

Maxwell A . Fung, MD Advanced Medical, Inc . Consultant

Pedram Gerami, BS, MD Castle Biosciences, Inc . Consultant DermTech, Inc . Consultant Myriad myPath® Consultant

Lynne J . Goldberg, MD Living Proof, Inc . Consultant

Alejandro A . Gru, MD Seattle Genetics Consultant

Molly A . Hinshaw, MD Accure Medical, LLC Founder/Owner

Dave S . Hoon, MSc, PhD Guardant Health, Inc . Consultant

M . Yadira Hurley, MD Abbott Laboratories Principal Investigator AbbVie Speaker, Principal Investigator Actelion Speaker Amgen Principal Investigator Anacor Pharmaceuticals, Inc . Other AstraZeneca Principal Investigator Castle Biosciences, Inc . Advisory Board Centocor Ortho Biotech, Inc . Principal Investigator Genentech, Inc . Principal investigator Pfizer, Inc. Principal Investigator Regeneron Principal Investigator XOMA (US) LLC Principal Investigator

Karl M . Napekoski, MD Myriad myPath® Speaker

Janis M . Taube, MD AstraZeneca Advisory Board Bristol-Myers Squibb Advisory Board Initiated Research Merck & Co ., Inc . Advisory Board

Michael T. Tetzlaff, MD, PhD Myriad myPath® Advisory Board Seattle Genetics Advisory Board

Claudia I . Vidal, MD, PhD Allergan Advisory Board

Page 14: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

14 www.asdp.org/AM16 #ASDP2016

Annual Award Recipients2016 Founders’ Award

Christopher R. Shea, MD Eugene J. Van Scott Professor in Dermatology Chief, Section of Dermatology University of Chicago Editor-in-Chief, Journal of Cutaneous Pathology

Christopher Shea, MD, earned his undergraduate degree at Brown University and his medical degree at George-town University . He completed a two-year basic research fellowship at the Wellman Laboratories at Massachusetts General Hospital (MGH) in Boston, where his investigations focused on targeting laser efforts on subcellular organelles such as mitochondria, principally using pathologic tech-niques including fluorescence microscopy and electron

microscopy, and with a focus on the role of oxidation-dependent pathways in these effects. He maintained this research program during the following three-year residency in dermatology at MGH, during which time he also held a faculty appointment in dermatol-ogy from Harvard Medical School . He went on to perform a dermatopathology fellowship at New York Hospital-Cornell . His post-training career has included service as assistant professor at Cornell, and as both associate and full professor at Duke University (where he directed the dermatopathology unit and the dermatopathology fellowship training program) . He has served as the national director of diagnostic quality programs for the American Society of Dermatopathology, and is currently on the editorial boards of several of the top dermatology and dermatopathology journals . He was appointed editor-in-chief of the Journal of Cutaneous Pathology in 2016 . Since 2001 he has been serving as profes-sor and chief of dermatology at the University of Chicago. In 2013 he was named the first Eugene J . Van Scott Professor in Dermatology . He has published more than 160 publica-tions, 48 book chapters, and authored a book in melanocytic neoplasms .

The 2016 Founders’ Award will be presented to Dr . Shea at the President’s Banquet Friday, October 28 .

Visit www.asdp.org/foundersaward for a list of previous Founders’ Award recipients.

Page 15: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 15

Gene

ral

Info

rmat

ion2016 Walter R. Nickel Award

Rosalie Elenitsas, MDProfessor of Dermatology Director of Dermatopathology Hospital of the University of Pennsylvania

Rosalie Elenitsas, MD, is the Herman Beerman Professor of Dermatology and Pathology at the Perelman School of Medicine at the University of Pennsylvania . Dr . Elenit-sas has been a faculty member at Penn since 1991 and has been director of the Dermatopathology Fellowship Program since 1998 . She has also been director of Penn Cutaneous Services since 1999 . Over the past 25 years, she has had a profound role in educating dermatopathology fellows and she is uniformly recognized by her students as

a model teacher . Her trainees have come from throughout the United States, as well as South America, Africa and Asia . Dr . Elenitsas is heavily involved in resident and medical student teaching . She is an internationally recognized expert in melanocytic lesions, and she has published more than 150 peer-reviewed studies, reviews and chapters, many related to evaluating the histopathology of melanocytic lesions . Dr . Elenitsas has served as associate editor of Lever’s Histopathology of the Skin since 1997 . For 15 years, she was director of Penn’s Dermatopathology Self-Assessment and Board Review Course, and she is currently on the faculty of the ASDP Essentials of Dermatopathology Board Review and MOC Course . She teaches a complete approach of dermatopathology including laboratory management, quality assurance and collegiality . Her teaching efforts represent much of the foundational dermatopathology knowledge for our fellows and residents . She has lectured nationwide and internationally . As a dedi-cated member of the ASDP, she currently serves on the Board of Directors, as the chair of the Maintenance of Certification Committee, and on the Fellows In-Service Assessment Writing Committee .

The 2016 Walter R . Nickel Award will be presented to Dr . Elenitsas at the President’s Banquet Friday, October 28 .

Visit www.asdp.org/walterrnickelaward for a list of previous Walter R. Nickel Award recipients.

Page 16: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of DermatopathologyThe American Society of Dermatopathology

16 www.asdp.org/AM16 #ASDP2016

Committee Meetings ScheduleAll committee meeting rooms are located on the 4th floor, unless otherwise noted. Committee meeting attendance is by invitation only .

Thursday, October 278:00 a.m. – 11:30 a.m.Board of Directors Meeting Waldorf, 3rd Floor

11:30 a.m. – 1:00 p.m.Dermatopathology Fellowship Training Directors Meeting Astoria, 3rd Floor

Friday, October 287:00 a.m. – 8:00 a.m.Membership Committee Meeting 4BHistory Ad Hoc Committee Meeting 4DJCP Editorial Board Meeting Waldorf, 3rd Floor

7:00 a.m. – 8:30 a.m.Appropriate Use Criteria Task Force Meeting 4A

8:00 a.m. – 9:00 a.m.Young Physicians’ Ad Hoc Committee Meeting 4B

9:00 a.m. – 10:00 a.m.Strategic Planning Committee Meeting 4A

10:00 a.m. – 11:00 a.m.Mentorship Awards Ad Hoc Committee Meeting 4BFellow In-Service Assessment Writing Ad Hoc Committee Meeting 4D

Saturday, October 297:00 a.m. – 8:00 a.m.Continuing Education & Research Committee Meeting 4B

7:00 a.m. – 8:30 a.m.Audit and Finance Joint Committee Meeting 4A

8:00 a.m. – 9:00 a.m.Peer Review Committee Meeting 4B

8:30 a.m. – 9:30 a.m.MOC-DP Committee Meeting 4CInformatics Committee Meeting 4D

Page 17: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 17

The American Society of Dermatopathology

9:00 a.m. – 10:00 a.m.Ethics Committee Meeting 4A

9:30 a.m. – 10:30 a.m.Diagnostic Quality Assurance Ad Hoc Committee Meeting 4CSocial Media Subcommittee Meeting 4D

10:00 a.m. – 11:00 a.m.Advocacy Committee Meeting 4A

10:30 a.m. – 11:30 a.m.Virtual Slide Library Meeting Astoria, 3rd Floor

2:00 p.m. – 3:30 p.m.Program Committee Meeting Astoria, 3rd Floor

Sunday, October 306:45 a.m. – 8:30 a.m.Board of Directors and Committee Chair Roundtable Waldorf, 3rd Floor

Corporate Partners and SponsorsThe American Society of Dermatopathology gratefully acknowledges the following 2016-2017 Corporate Partners and 53rd Annual Meeting Sponsors and Advertisers .

Their generous support of ASDP makes it possible for us to provide access to educational and scientific events and activities to as many dermatopathologists and dermatopathol-ogists-in-training as possible .

Gene

ral

Info

rmat

ion

The American Society of Dermatopathology (ASDP) does not endorse any medical product, treatment or service sold by any corporation, institution or member supporting our organization. Corporate Partnerships and sponsorships are not an endorsementof a product or service and may not be represented as such, in any way. The use of the ASDP name and/or logo, or representation of such, without the written consent of the ASDP Executive is strictly prohibited.

Platinum PartnerMyriad myPath®

Gold PartnerCastle BioSciences, Inc .

Bronze PartnerLondon Dermatopathology Symposium

Contributing PartnersRaymond L . Barnhill, MD, Garrett T . Desman,

MD & McGraw-Hill Education Lyn M . Duncan, MDMeera Mahalingam, MD, PhD, FRCPathLeonard C . Sperling, MD

53rd Annual Meeting SponsorsProPath® DermatopathologyStemlineISDP 2017

Page 18: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

18 www.asdp.org/AM16 #ASDP2016

Program-at-a-GlanceThe Plenary Program is open to all meeting attendees. Your full registration to the ASDP Annual Meeting includes:

➜ Future Directions in Dermatopathology: A Forum for Career Development (formerly the Young Physicians’ Forum)

➜ 17th Annual Duel in Dermatopathology

➜ Oral Abstract Sessions 1-3

➜ Short Courses I-IV

➜ Hermann Pinkus Memorial Basic Science Course

➜ President’s Address

➜ 2016 Elson B . Helwig Memorial Lecture

➜ Fellows’ Presentations

➜ Evening Slide Symposium

➜ 24-hour access to the Evening Slide Symposium Slides

➜ Two Poster Sessions

➜ 24-hour access to the Slide Library

Optional Courses & Events may require additional fees and include:

➜ Consultations in Dermatopathology

➜ Mini Course - Alopecia: Step-by-Step

➜ Self-Assessment in Dermatopathology

➜ President’s Reception & Banquet

➜ Meet the Program Directors – No additional registration fee, but registration is required.

Wednesday, October 262:00 p .m . – 6:00 p .m . Registration Open 8th Street Registration Counters

2:00 p .m . – 6:00 p .m . Dermatopathology Bookstore Continental Ballroom Open Foyer, Lobby Level

2:00 p .m . – 6:00 p .m . Speaker Ready Room Open 8th Street Registration Counters

Page 19: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Prog

ram

-at-a

- Gl

ance

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 19

Thursday, October 27* Optional Courses require an additional fee and online registration.

7:00 a .m . – 6:00 p .m . Registration and Information 8th Street Registration Counters

7:00 a .m . – 6:00 p .m . Dermatopathology Bookstore Continental Ballroom Foyer, Lobby Level

7:00 a .m . – 8:00 p .m . Speaker Ready Room 8th Street Registration Counters

Opens at 8:00 a .m . Evening Slide Symposium Preview PDR #4, 3rd Floor Open 24-hours!

8:00 a .m . – 11:30 a .m . Board of Directors’ Meeting Waldorf, 3rd Floor

8:00 a .m . – Noon Poster Session 1 Set-up Continental Ballroom, Lobby Level

8:00 a .m . – Noon ASDP Art Show Set-up Continental Ballroom Foyer, Lobby Level

9:00 a .m . – Noon Mini Course* Grand Ballroom, 2nd Floor Alopecia: Step-by-Step

9:00 a .m . – 10:15 a .m . Consultation 100* PDR #1, 3rd Floor Consultation 101* PDR #2, 3rd Floor Consultation 102* PDR #3, 3rd Floor

10:45 a .m . – Noon Consultation 103* PDR #1, 3rd Floor Consultation 104* PDR #2, 3rd Floor Consultation 105* PDR #3, 3rd Floor

11:30 a .m . – 1:00 p .m . Dermatopathology Fellowship Astoria, 3rd Floor Training Directors Meeting

Opens at 1:00 p .m . Poster Session 1 Viewing Continental Ballroom, Open 24-hours! Lobby Level

Opens at 1:00 p .m . ASDP Art Show Continental Ballroom Foyer, Lobby Level

1:00 p .m . – 2:15 p .m . Consultation 106* PDR #1, 3rd Floor Consultation 107* PDR #2, 3rd Floor Consultation 108* PDR #3, 3rd Floor

1:00 p .m . – 3:00 p .m . Self-Assessment Session A* Williford B/C, 3rd Floor

1:00 p .m . – 3:15 p .m . Short Course I Grand Ballroom, 2nd Floor Best Practices: From Guidelines to Appropriate Use

2:45 p .m . – 4:00 p .m . Consultation 109* PDR #1, 3rd Floor Consultation 110* PDR #2, 3rd Floor Consultation 111* PDR #3, 3rd Floor

Page 20: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

20 www.asdp.org/AM16 #ASDP2016

3:15 p .m . – 3:45 p .m . Refreshment Break Continental Ballroom, Lobby Level

3:45 p .m . – 5:15 p .m . Oral Abstract Session 1 Grand Ballroom, 2nd Floor

4:00 p .m . – 6:00 p .m . Self-Assessment Session B* Williford B/C, 3rd Floor

4:30 p .m . – 5:45 p .m . Consultation 112* PDR #1, 3rd Floor Consultation 113* PDR #2, 3rd Floor Consultation 114* PDR #3, 3rd Floor

5:15 p .m . – 6:45 p .m . Duel in Dermatopathology Grand Ballroom, 2nd Floor

7:00 p .m . – 9:00 p .m . Future Directions in Grand Ballroom, Dermatopathology: 2nd Floor A Forum for Career Development (formerly the Young Physicians’ Forum)

9:00 p .m . – 11:00 p .m . Young Physicians’ Reception Normandie, 2nd Floor

Friday, October 28*Optional Courses require an additional fee and online registration.

Open 24-hours Evening Slide Symposium Preview PDR #4, 3rd Floor

Open 24-hours ASDP Art Show Continental Ballroom Foyer, Lobby Level

Open until 5:00 p .m . Poster Session 1 Viewing Continental Ballroom, Lobby Level

6:30 a .m . – 8:00 a .m . Continental Breakfast Normandie, 2nd Floor

6:30 a .m . – 5:00 p .m . Registration and Information 8th Street Registration Counters

6:30 a .m . – 5:00 p .m . Dermatopathology Continental Ballroom Foyer, Bookstore Lobby Level

6:30 a .m . – 6:00 p .m . Speaker Ready Room 8th Street Registration Counters

7:00 a .m . – 8:15 a .m . Consultation 200* PDR #1, 3rd Floor Consultation 201* PDR #2, 3rd Floor Consultation 202* PDR #3, 3rd Floor

7:00 a .m . – 9:00 a .m . Self-Assessment Session C* Williford B/C, 3rd Floor

8:00 a .m . – Noon Short Course II Grand Ballroom, 2nd Floor Melanocytic Lesions and Sacred Cows: What is True and What is Dogma

8:45 a .m . – 10:00 a .m . Consultation 203* PDR #1, 3rd Floor Consultation 204* PDR #2, 3rd Floor Consultation 205* PDR #3, 3rd Floor

Thursday, October 27 (continued)

Page 21: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Prog

ram

-at-a

- Gl

ance

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 21

9:45 a .m . – 10:15 a .m . Refreshment Break Continental Ballroom, Lobby Level

10:00 a .m . – Noon Self-Assessment Session D* Williford B/C, 3rd Floor

10:30 a .m . – 11:45 a .m . Consultation 206* PDR #1, 3rd Floor Consultation 207* PDR #2, 3rd Floor Consultation 208* PDR #3, 3rd Floor

Noon – 1:30 p .m . Lunch on Your Own

Opens at 1:00 p .m . Slide Library Williford B/C, Open 24-hours! 3rd Floor

1:30 p .m . – 2:45 p .m . Consultation 209* PDR #1, 3rd Floor Consultation 210* PDR #2, 3rd Floor Consultation 211* PDR #3, 3rd Floor

1:30 p .m . – 3:00 p .m . Oral Abstract Session 2 Grand Ballroom, 2nd Floor

2:00 p .m . – 6:15 p .m . Self-Assessment International Ballroom North, Discussion* 2nd Floor

3:15 p .m . – 4:30 p .m . Consultation 212* PDR #1, 3rd Floor Consultation 213* PDR #2, 3rd Floor Consultation 214* PDR #3, 3rd Floor

3:15 p .m . – 6:30 p .m . Hermann Pinkus Memorial Grand Ballroom, Basic Science Course 2nd Floor

4:15 p .m . – 5:00 p .m . Refreshment Break Continental Ballroom, Lobby Level

4:15 p .m . – 5:00 p .m . Poster Session 1 Defense Continental Ballroom, Lobby Level

5:00 p .m . – 6:00 p .m . Poster Session 1 Dismantle Continental Ballroom, Lobby Level

5:00 p .m . – 6:15 p .m . Consultation 215* PDR #1, 3rd Floor Consultation 216* PDR #2, 3rd Floor Consultation 217* PDR #3, 3rd Floor

6:00 p .m . – 10:00 p .m . Poster Session 2 Set-up Continental Ballroom, Lobby Level

7:00 p .m . – 11:00 p .m . President’s Reception International Ballroom South, and Banquet* 2nd Floor

Page 22: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

22 www.asdp.org/AM16 #ASDP2016

Saturday, October 29

* Optional Courses require additional registration fee and online registration.

** Meet the Program Directors is open to dermatology and pathology residents. There is no additional fee but registration is required.

Open 24-hours Evening Slide Symposium Preview PDR #4, 3rd Floor

Open 24-hours Slide Library Williford B/C, 3rd Floor

Open 24-hours ASDP Art Show Continental Ballroom Foyer, Lobby Level

6:00 a .m . – 8:00 a .m . Poster Session 2 Set-up Continental Ballroom, Lobby Level

6:30 a .m . – 8:00 a .m . Continental Breakfast Normandie Lounge, 2nd Floor

6:30 a .m . – 5:00 p .m . Registration and Information 8th Street Registration Counters

6:30 a .m . – 5:00 p .m . Dermatopathology Continental Ballroom Foyer, Bookstore Lobby Level

6:30 a .m . – 6:00 p .m . Speaker Ready Room 8th Street Registration Counters

6:45 a .m . – 8:00 a .m . Meet the Program Directors** Boulevard, 2nd Floor

7:00 a .m . – 8:15 a .m . Consultation 300* PDR #1, 3rd Floor Consultation 301* PDR #2, 3rd Floor Consultation 302* PDR #3, 3rd Floor

8:00 a .m . – 12:15 p .m . Short Course III Grand Ballroom, 2nd Floor Everything You Always Wanted to Know About Nails But Were Afraid to Ask

Opens at 8:00 a .m . Poster Session 2 Viewing Continental Ballroom, Open 24-hours! Lobby Level

8:45 a .m . – 10:00 a .m . Consultation 303* PDR #1, 3rd Floor Consultation 304* PDR #2, 3rd Floor Consultation 305* PDR #3, 3rd Floor

10:00 a .m . – 10:45 a .m . Refreshment Break Continental Ballroom, Lobby Level

10:00 a .m . – 10:45 a .m . Poster Session 2 Defense Continental Ballroom, Lobby Level

10:45 a .m . – Noon Consultation 306* PDR #1, 3rd Floor Consultation 307* PDR #2, 3rd Floor Consultation 308* PDR #3, 3rd Floor

12:30 p .m . – 1:45 p .m . Annual Membership Business International Ballroom Meeting and Luncheon South, 2nd Floor

1:45 p .m . – 3:00 p .m . Consultation 309* PDR #1, 3rd Floor Consultation 310* PDR #2, 3rd Floor Consultation 311* PDR #3, 3rd Floor

Page 23: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Prog

ram

-at-a

- Gl

ance

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 23

1:50 p .m . – 2:00 p .m . Duel in Dermatopathology Grand Ballroom, Awards Presentation 2nd Floor

2:00 p .m . – 4:00 p .m . Fellows’ Presentations Grand Ballroom, 2nd Floor

2:00 p .m . – 3:30 p .m . Program Committee Meeting Astoria, 3rd Floor

4:00 p .m . – 4:30 p .m . Refreshment Break Continental Ballroom, Lobby Level

4:30 p .m . – 5:00 p .m . President’s Address International Ballroom North, 2nd Floor

5:00 p .m . – 6:00 p .m . Elson B. Helwig International Ballroom North, Memorial Lecture 2nd Floor

6:00 p .m . – 7:15 p .m . Consultation 312* PDR #1, 3rd Floor Consultation 313* PDR #2, 3rd Floor Consultation 314* PDR #3, 3rd Floor

6:00 p .m . – 9:00 p .m . Evening Slide International Ballroom North, Symposium 2nd Floor

Sunday, October 30 * Optional Courses require additional registration fee and online registration.

Open until 11:00 a .m . Evening Slide Symposium PDR #4, 3rd Floor Slide Viewing

Open until 11:00 a .m . Poster Session 2 Viewing Continental Ballroom, Lobby Level

Open until 11:00 a .m . Slide Library Williford B/C, 3rd Floor

Open until 11:00 a .m . ASDP Art Show Continental Ballroom Foyer, Lobby Level

6:30 a .m . – 8:00 a .m . Continental Breakfast Normandie, 2nd Floor

6:30 a .m . – 11:00 a .m . Dermatopathology Continental Ballroom Foyer, Bookstore Lobby Level

6:30 a .m . – Noon Registration and Information 8th Street Registration Counters

6:30 a .m . – Noon Speaker Ready Room 8th Street Registration Counters

6:45 a .m . – 8:30 a .m . Board of Directors’ and Committee Waldorf, 3rd Floor Chair Roundtable

7:00 a .m . – 8:15 a .m . Consultation 400* PDR #1, 3rd Floor Consultation 401* PDR #2, 3rd Floor Consultation 402* PDR #3, 3rd Floor

Page 24: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of DermatopathologyThe American Society of Dermatopathology

24 www.asdp.org/AM16 #ASDP2016

7:30 a .m . – 8:30 a .m . Oral Abstract Session 3 Grand Ballroom, 2nd Floor

8:30 a .m . – 8:45 a .m . Physician-in-Training Continental Ballroom, Awards Presentation Lobby Level

8:45 a .m . – 10:00 a .m . Consultation 403* PDR #1, 3rd Floor Consultation 404* PDR #2, 3rd Floor Consultation 405* PDR #3, 3rd Floor

8:45 a .m . – Noon Short Course IV Grand Ballroom, 2nd Floor Update on Cutaneous Lymphoma

10:00 a .m . – Noon Refreshments Grand Ballroom, 2nd Floor

10:30 a .m . – 11:45 a .m . Consultation 406* PDR #1, 3rd Floor Consultation 407* PDR #2, 3rd Floor Consultation 408* PDR #3, 3rd Floor

11:00 a .m . – Noon Poster Session 2 Dismantle Continental Ballroom, Lobby Level

11:00 a .m . – Noon ASDP Art Show Dismantle Continental Ballroom Foyer, Lobby Level

Closes at 11:00 a .m . Slide Library Williford B/C, 3rd Floor

Closes at 11:00 a .m . Evening Slide Symposium PDR #4, 3rd Floor Slide Viewing

Noon ASDP 53rd Annual Meeting Adjourns

Sunday, October 30 (continued)

Congratulations to the 2016-2017 ASDP Mentorship in Dermatopathology Award Recipients

Diana Braswell, MDUniversity of South Florida Morsani College of MedicineMentor: Drazen Jukic, MD, PhDGeorgia Dermatology & Skin Cancer Center

Haider Mejbel, MDBaylor College of MedicineMentor: Bruce Smoller, MDUniversity of Rochester

Cuong Nguyen, MDUniversity of MinnesotaMentor: Carrie Kovarik, MDUniversity of Pennsylvania

Brian Tjarks, MDUniversity of South DakotaMentor: Tammie C. Ferringer, MDGeisinger Medical Center

Be sure to visit this year’s ASDP Mentorship Awards in Dermatopathology poster presentations on display in the

Continental Ballroom, Lobby Level.

Page 25: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 25

The American Society of Dermatopathology

Thur

sday

, O

ctob

er 8

Plenary ProgramShort Course IBest Practices: From Guidelines to Appropriate UseWith Audience Response System

Thursday, October 271:00 p.m. – 3:15 p.m.Grand Ballroom, 2nd Floor

Course Director:Tammie C . Ferringer, MDGeisinger Medical Center

2.25 AMA PRA Category 1 CreditsTM 2.25 AAD Recognized Credit20 MOC SA Question Credits

As the healthcare landscape changes, dermatopathologists must determine the most cost-effective and efficient method of approaching common scenarios such as when to order and how to interpret clonality studies, molecular tests, and immunohistochemical screening. Guidelines in best practice can decrease costs, errors and inefficiency, as well as improve reimbursement, provide a legal standard for comparison, and improve patient diagnosis and outcome . Through the use of an audience response system, participants will learn how the majority of their peers approach common scenarios . Without ev-idence-based standards, coverage and reimbursement are in jeopardy . The ASDP’s appro-priate use task force will outline the process of developing appropriate use criteria .

Faculty and Course Outline1:00 p .m . – 1:05 p .m . Introduction Tammie C . Ferringer, MD Geisinger Medical Center

1:05 p .m . – 1:20 p .m . Guidelines: The Future of Dermatopathology? Dirk M . Elston, MD Medical University of South Carolina

1:20 pm . – 1:40 p .m . Appropriate Ancillary Pathology Test Utilization Elaine K . Jeter, MD MolDX Medical Director

1:40 p .m . – 1:50 p .m . Appropriate Use Criteria: What Is the ASDP Doing? M . Yadira Hurley, MD Saint Louis University School of Medicine

1:50 p .m . – 2:10 p .m . Molecular Studies in Melanocytic Lesions Jinah Kim, MD, PhD Stanford University

Page 26: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

26 www.asdp.org/AM16 #ASDP2016

2:10 p .m . – 2:20 p .m . Muir Torre Screening in Sebaceous Lesions Claudia I . Vidal, MD, PhD Saint Louis University

2:20 p .m . – 2:30 p .m . HPV Subtyping Brandon Litzner, MD Kansas City Medical Center

2:30 p .m . – 2:45 p .m . Clonality Studies in Lymphoproliferative Disorders Uma N . Sundram, MD, PhD Associated Pathology Medical Group

2:45 p .m . – 3:00 p .m . Molecular Diagnosis in Soft Tissue Tumors Jessica A . Kozel, MD, FASDP University of Nebraska Medical Center

3:00 p .m . – 3:15 p .m . Q&A

Upon completion of this course, participants should be able to: ➜ Aptly order and interpret clonality studies, molecular tests and

immunohistochemical screening .

➜ Decrease costs, errors and inefficiencies in daily practice.

➜ Improve reimbursement and patient diagnoses and outcomes .

➜ Provide a legal standard for comparison by utilizing best practice guidelines .

➜ Advocate the need for additional evidence and supporting material .

Plenary Program (continued)Short Course IBest Practices: From Guidelines to Appropriate Use (continued)

Page 27: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Thur

sday

, N

ovem

ber 6

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 27

Oral Abstract Session 1Thursday, October 273:45 p.m. – 5:15 p.m.Grand Ballroom, 2nd Floor

Course Moderator:M . Yadira Hurley, MDSaint Louis University School of Medicine

1.5 AMA PRA Category 1 CreditsTM

1.5 AAD Recognized Credit

Abstracts presented in Oral Abstract Session 1 can be found in the abstract PDF book available for download at www .asdp .org/AM16 . Abstracts are listed in the order of presentation .

Time Title Speaker

3:45 p .m . – 3:55 p .m . Immunohistochemical Analysis of P40 and Androgen Receptor in the Spectrum of Sebaceous Tumors and Its Utility in Distinguishing Sebaceous Carcinoma from Basal Cell Carcinoma

Smita C . Patel, MD

3:55 p .m . – 4:05 p .m . 5-Hydroxymethlyctosine in Histologically Ambiguous, Heavily Pigmented Melanocytic Lesions: A Comparative, Immunohistochemical, Retrospective Cohort Study

Jonathan J . Lee, MD

4:05 p .m . – 4:15 p .m . Tumor-Normal Whole Exome Sequencing of Subcutaneous Panniculitis-like T-cell Lymphoma, Lupus Panniculitis, and Systemic Peripheral T-cell Lymphoma

Sebastian Fernandez-Pol, MD, PhD

Thur

sday

, O

ctob

er 2

7

Page 28: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

28 www.asdp.org/AM16 #ASDP2016

4:15 p .m . – 4:25 p .m . Differentiation of Benign Melanocytic Nevi from Malignant Melanomas Solely by Nuclear Features

Nemanja Rodic, MD, PhD

4:25 p .m . – 4:35 p .m . Expression of SPARC Immunohistochemistry in Cutaneous Angiosarcoma and Selected Mimickers

Shakuntala H . Mauzo, MD

4:35 p .m . – 4:45 p .m . p15, a Potential Biomarker of Spitzoid Melanocytic Lesions

Sophia A . Ma, MD

4:45 p .m . – 4:55 p .m . Analysis of Immune Signatures in Longitudinal Tumor Samples Yields insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Pei-Ling Chen, MD, PhD

4:55 p .m . – 5:05 p .m . High-throughput Sequencing of TCRB and TCRG in Multiple Biopsies from Patients with Atypical Lymphoid Infiltrates to Evaluate for Mycosis Fungoides and Sézary Syndrome

Ryanne A . Brown, MD, MBA

5:05 p .m . – 5:15 p .m . Genetic Signature Testing in Cutaneous Melanoma Correlates Well with Current Histopathologic and Surgical Staging Parameters

Alae Abod Yaseen, MD

Upon completion of this course, participants should be able to:

➜ Identify various clinical and basic science topics within dermatopathology .

➜ Exemplify and promote exchange of new ideas and concepts within the field of dermatopathology .

➜ Describe innovative investigative studies and tools pertaining to bench and translational research .

➜ Compare unique pathological perspectives and concepts as they relate to individual and groups of cases .

Plenary Program (continued)Oral Abstract Session 1 (continued)

Page 29: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 29

17th Annual Duel in Dermatopathology Resident Abstract CompetitionThursday, October 275:15 p.m. – 6:45 p.m.Grand Ballroom, 2nd Floor

Course Moderator:Leslie Robinson-Bostom, MDRhode Island Hospital

1.5 AMA PRA Category 1 CreditsTM

1.5 AAD Recognized Credit

Abstracts presented in the Duel in Dermatopathology Resident Abstract Competition can be found in the abstract PDF book available for download at www .asdp .org/AM16 . The American Society of Dermatopathology is pleased to present the 17th Annual Duel in Dermatopathology Abstract Competition for dermatology and pathology residents . This resident forum consists of succinct five-minute presentations. Prizes for first, second and third place will be awarded for the best clinical-pathologic case reports . Presentations will be evaluated on content, form, instructive value to dermatopathology and execution .

Award winners will be announced at 1:50 p.m., Saturday, October 29, immediately prior to the Fellows’ Presentations.

Time Title Speaker

5:15 p .m . – 5:20 p .m . Multifocal but Non-Disseminated Phaeohyphomycosis in a Healthy Man Via a Unique Mechanism: Ejection from MVA into a Vegetable Field Resulting in Contaminated Skin Wounds

Ryan Campbell, MD

5:20 p .m . – 5:25 p .m . Cutaneous Granular Cell Angiosarcoma: A Rare Histologic Variant Closely Mimicking Benign Granular Cell Tumor

Daniel C . Skipper, DO

5:25 p .m . – 5:30 p .m . Deficiency of Adenosine Deaminase 2 in a 13-year-old Female with Recurrent Ischemic Strokes, Vasculitis and Livedo Racemosa

Mustafa M . Mohammad, MD

Thur

sday

, O

ctob

er 2

7

Page 30: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

30 www.asdp.org/AM16 #ASDP2016

Time Title Speaker

5:30 p .m . – 5:35 p .m . Unique Pattern of Response to BRAF Inhibition in a Case of Advanced Melanoma

Diana Braswell, MD

5:35 p .m . – 5:40 p .m . Syphilitic Proctocolitis in HIV-negative Female Diagnosed Retrospectively After Skin Biopsy

Elisheva Shanes, MD

5:40 p .m . – 5:45 p .m . Eccrine Syringofibroadenoma in Association with Acquired Epidermodysplasia Verruciformis

Timothy Tan, DO

5:45 p .m . – 5:50 p .m . Two Faces of Melanoma: A Case of Melanoma with Transformation from Spindle Cell to Basaloid Histomorphology

Natasha K . Klimas, MD

5:50 p .m . – 5:55 p .m . Galli-Galli Disease: A Rare Acantholytic Variant of Dowling-Degos Disease

Audrey Green, MD

5:55 p .m . – 6:00 p .m . Is There a Clinically Distinct Subset of Marginal Zone B-cell Lymphomas with Epidermotropism? A Case Report and Review of the Literature

Amin A . Hedayat, MD

6:00 p .m . – 6:05 p .m . Molecular and Histologic Assessment of a Congenital Melanoma and Proliferative Nodules Arising in Medium Sized Congenital Nevus in a New Born

Maria C . Isales, MD, MPH

6:05 p .m . – 6:10 p .m . A Question of Origin: A Case of Cellular Neurothekeoma Merging with an Intradermal Nevus

Brianne Dickey, MD

Plenary Program (continued)17th Annual Duel in Dermatopathology Resident Abstract Competition (continued)

Page 31: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 31

6:10 p .m . – 6:15 p .m . A Rare Case of Cutaneous Blastoid Mantle Cell Lymphoma

Ata Moshiri, MD, MPH

6:15 p .m . – 6:20 p .m . AGEP Secondary to Stribild in an AIDS Patient

Aimee Coscarart, MD

6:20 p .m . – 6:25 p .m . Hypertensive Leg Ulcers (Martonell’s ulcer), a Forgotten Entity

Georgina Uberti, MD

6:25 p .m . – 6:30 p .m . Primary Cutaneous Low-grade Neuroendocrine Tumor: An Exceedingly Rare Entity

Tiffany Chen, MD

6:30 p .m . – 6:35 p .m . Amyloidosis of AL Type Presenting with Large Cutaneous Plaques and a Breast Mass in a Patient with Scleroderma in the Absence of Plasma Cell Dyscrasia

Nariman A . Nawar, MD

6:35 p .m . – 6:40 p .m . Compound Melanocytic Nevus Arising Within an Organoid Nevus: A Rarely Reported Clinical and Histopathologic Finding in a Girl with Phakomatosis Pigmentokeratotica

Amber Fresco, MD

6:40 p .m . – 6:45 p .m . Pembrolizumab-induced Widespread Ulcerations in a Patient with Metastatic Melanoma and Squamous Cell Carcinoma

Dinesh Pradhan, MD

Upon completion of this course, participants should be able to: ➜ Expand diagnostic skills by recognizing clinicopathologic entities presented via

abstracts .

➜ Utilize and interpret diagnostic clues and techniques identified by literature review of these cases .

Thur

sday

, O

ctob

er 2

7

Page 32: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

32 www.asdp.org/AM16 #ASDP2016

Future Directions in Dermatopathology: A Forum for Career Development(formerly the Young Physicians’ Forum)

Thursday, October 277:00 p.m. – 9:00 p.m.Grand Ballroom, 2nd Floor

Course Directors:Liaqat Ali, MDPinkus Dermatopathology Laboratory

Karl M . Napekoski, MDLaboratory and Pathology Diagnostics, LLC

2 AMA PRA Category 1 CreditsTM

2 AAD Recognized Credit

All meeting attendees are invited to join us for this informative program . Formerly the Young Physicians’ Forum, this year’s Future Directions in Dermatopathology session will include a variety of topics relevant to early and experienced dermatopathologists .

Physicians are faced with many competing priorities and high-impact career decisions as they make the transition from fellow to attending and continue to face life-defining professional and personal decisions throughout their careers, including how to approach securing first jobs, contract negotiation, academic promotion, etc. In addition, they are faced with the challenge of balancing the priorities of patient care, teaching, career advancement and personal life . Don’t miss this unique opportunity to get advice on these topics from a diverse group of speakers at various stages in their careers .

Faculty and Course Outline7:00 p .m . – 7:05 p .m . Introductions

7:05 p .m . – 7:25 p .m . Early Care Dermatopathology Practice: Assessment of New Techniques and Use of Consultation in Melanocytic Tumors Lyn M . Duncan, MD Massachusetts General Hospital

7:25 p .m . – 7:45 p .m . Starting Out in Academics Lori Lowe, MD University of Michigan

Plenary Program (continued)

Page 33: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 33

7:45 p .m . – 8:05 p .m . Promotion and Contract Negotiation in Academics Steven D . Billings, MD Cleveland Clinic

8:05 p .m . – 8:25 p .m . Should You Start Your Own Dermatopathology Laboratory? Michael S . Rabkin, MD, PhD Rabkin Dermatopathology Laboratory, P.C.

8:25 p .m . – 9:00 p .m . Q&A and Closing Remarks

Upon completion of this course, participants should be able to:

➜ Identify resources, tools and skill sets that physicians can utilize to support decision making at various stages of their careers .

➜ Utilize information technology to successfully manage the early years of dermatopathology practice .

➜ Apply appropriate tools and skills to achieve work-life balance and ease legal concerns .

6th Annual Young Physicians’ ReceptionThursday, October 279:00 p.m. – 11:00 p.m.Normandie, 2nd Floor

Dermatology and pathology residents, dermatopathology fellows and dermatopathologists in their first seven years of practice are invited to network with the Future Directions in Dermatopathology faculty members and other dermatopathology role models at the Young Physicians’ Reception . Hors d’oeuvres and refreshments will be served . Don’t miss this unique opportunity to develop professional relationships with the leaders in dermatopathology as well as your peers .

Thur

sday

, O

ctob

er 2

7

Page 34: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

34 www.asdp.org/AM16 #ASDP2016

Short Course IIMelanocytic Lesions and Sacred Cows: What is True and What is Dogma?Friday, October 288:00 a.m. – NoonGrand Ballroom, 2nd Floor

Course Director:Raymond L . Barnhill, MDInstitut Curie and University of Paris Descartes

3.5 AMA PRA Category 1 CreditsTM 3.5 AAD Recognized Credit

Dermatopathologists face a host of recurring key issues and problems with reference to interpretation and management of melanocytic lesions . This course rigorously examines some of the sacred cows and dogmas commonly associated with melanocytic lesions that have often been perpetuated ad infinitum in this field. The goals of the course are to dispel and expunge fuzzy thinking and untruth as much as possible with critical analysis and objective information .

Faculty and Course Outline8:00 a .m . – 8:25 a .m . The Molecular Landscape of Pediatric Melanocytic Neoplasms: A Critical Re-examination and New

Insights Armita Bahrami, MD St. Jude Children’s Research Hospital, Memphis

8:25 a .m . – 8:50 a .m . Is There a Role for Immunohistochemistry in Melanocytic Lesions: Use It or Lose It? Lori Lowe, MD University of Michigan

8:50 a .m . – 9:15 a .m . Surgical Intervention for Melanocytic Lesions: What Makes Sense and What Does Not? Klaus J . Busam, MD Memorial Sloan Kettering Cancer Center

9:15 a .m . – 9:45 a .m . Histopathological Interpretation of Melanocytic Lesions: Discordance and the Way Forward Michael W . Piepkorn, MD, PhD University of Washington

9:45 a .m . – 10:15 a .m . Refreshment Break

Plenary Program (continued)

Page 35: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 35

Frid

ay,

Oct

ober

28

10:15 a .m . – 10:40 a .m . Mechanisms of Melanoma Metastasis: Critique and New Observations Raymond L . Barnhill, MD Institut Curie and University of Paris Descartes

10:40 a .m . – 11:05 a .m . PD-L1 and PD-1 Expression and Immune Cell Infiltrates in Melanoma: A Critical Analysis and Update Janis M . Taube, MD Johns Hopkins University

11:05 a .m . – 11:30 a .m . The Classification of Melanoma Update: How Many Melanomas Exist? Boris C . Bastian, MD University of California San Francisco

11:30 a .m . – Noon Q&A and Closing Remarks

Upon completion of this course, participants should be able to: ➜ Apply objective techniques for the conventional microscopic, immunhistochemical

and molecular evaluation and diagnosis of melanocytic lesions .

➜ Implement best practice criteria for sentinel lymph node biopsy and management of margins for melanocytic lesions and melanoma .

➜ Use existing and new data to assess metastases and antitumor immune status in melanoma .

➜ Employ the current classification of melanocytic lesions and melanoma to make correct diagnoses in every day practice .

Page 36: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

36 www.asdp.org/AM16 #ASDP2016

Oral Abstract Session 2Friday, October 281:30 p.m. – 3:00 p.m.Grand Ballroom, 2nd Floor

Course Moderator:Nooshin K . Brinster, MDNew York University 1.5 AMA PRA Category 1 CreditsTM 1.5 AAD Recognized Credit

Abstracts presented in Oral Abstract Session 2 can be found in the abstract PDF book available for download at www .asdp .org/AM16 . Abstracts are listed in the order of presentation .

Time Title Speaker1:30 p .m . – 1:40 p .m . Skin Biopsy Trends and

Associated Health Care Utilization

Toshi Ghosh, MD

1:40 p .m . – 1:50 p .m . Dual Expression of MYC and Beta-adrenergic Receptors in Cutaneous Angiosarcoma

Laura Gray Pruitt, MD

1:50 p .m . – 2:00 p .m . Direct Immunofluorescence (DIF) Testing in Vasculitis — A Single Institution Experience with Henoch Schönlein Purpura

Patrick Feasel, MD

2:00 p .m . – 2:10 p .m . Increasing Concordance for Atypical Melanocytic Lesions Using NDER, a Novel Web Application

Greg Cheeney, MD

2:10 p .m . – 2:20 p .m . Genomic Profile of Pigmented Epithelioid Melanocytic Lesions

Jarish N . Cohen, MD, PhD

Plenary Program (continued)

Page 37: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 37

2:20 p .m . – 2:30 p .m . Mutational Profile of Combined Squamous and Merkel Cell Carcinoma is Comparable to de novo Squamous Cell Carcinoma But Not Pure Merkel Cell Carcinoma

Melissa Pulitzer, MD

2:30 p .m . – 2:40 p .m . Loss of Retinoblastoma Protein Expression in Pleomorphic Fibroma: An Immunohistochemical and Genomic Analysis

Brian R . Hinds, MD

2:40 p .m . – 2:50 p .m . Mismatch Repair Deficiency as a Low-frequency Driver Event in Anorectal Melanoma

Basil A . Horst, MD

2:50 p .m . – 3:00 p .m . T-cell Receptor High-throughput Sequencing (TCR-HTS) Distinguishes a Lymphomatoid Drug Reaction from CTCL

Nick R . Love, PhD

Upon completion of this course, participants should be able to: ➜ Identify various clinical and basic science topics within dermatopathology .

➜ Exemplify and promote exchange of new ideas and concepts within the field of dermatopathology .

➜ Describe innovative investigative studies and tools pertaining to bench and transla-tional research .

➜ Compare unique pathological perspectives and concepts as they relate to individual and groups of cases .

Frid

ay,

Oct

ober

28

Page 38: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

38 www.asdp.org/AM16 #ASDP2016

Hermann Pinkus Memorial Basic Science CourseFriday, October 283:15 p.m. – 6:30 p.m.Grand Ballroom, 2nd Floor

Course Director:Melissa Pulitzer, MDMemorial Sloan Kettering Cancer Center

2.5 AMA PRA Category 1 CreditsTM 2.5 AAD Recognized Credit

Pathology of the skin results from a broad array of familial, individual and environmental cofactors . The understanding of these cofactors serves to enhance our ability to accurately and meaningfully diagnose disease for treatment using current therapeutic strategies . However, this understanding also enables us to reconsider the significance of some diagnoses in the context of new information . This year’s Hermann Pinkus Basic Science Course will explore the findings of macrocosmic genome-wide association studies in skin cancers, microcosmic (chromosome-wide) contributions of genetic translocations in cutaneous malignancies, structural-level roles of gap-junctions in genodermatoses, and immune-level functions of immune subsets in inflammatory disease and cancer, to highlight the complex interaction of nature and nurture in cutaneous disease states .

Faculty and Course Outline3:15 p .m . – 3:45 p .m . Skin Cancer: From Epidemiology to Multidisciplinary Research and Network Medicine Jiali Han, PhD Indiana University

3:45 p .m . – 4:15 p .m . Connexin Channels in Genodermatoses Thomas White, MD Stony Brook University School of Medicine

4:15 p .m . – 5:00 p .m . Refreshment Break

5:00 p .m . – 5:40 p .m . Liquid Biopsy Utility in Early Stage Cutaneous Melanoma Patients Dave S . Hoon, MSc, PhD John Wayne Cancer Institute

Plenary Program (continued)

Page 39: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 39

5:40 p .m . – 6:20 p .m . Genomic Sequencing of Cutaneous T-Cell Lymphomas Kojo Elenitoba-Johsnon, MD University of Pennsylvania

6:20 p .m . – 6:30 p .m . Q&A

Upon completion of this course, participants should be able to: ➜ Explain the applicability of findings from genome-wide association studies in

assessing individuals risk for skin cancers .

➜ Identify key structural deficits that contribute to blistering disease in skin.

➜ Describe the role of key dendritic cells in normal skin immune homeostasis .

➜ Discuss clinically relevant chromosomal translocations that should be assessed, based on pathologic or immunophenotypic features of cutaneous malignancies .

Frid

ay,

Oct

ober

28

ASDP Art Show Thursday, October 27 – Sunday, October 30

Continental Ballroom Foyer, Lobby Level

The Young Physicians’ Committee is sponsoring an event showcasing the artistic talents of the ASDP 53rd Annual Meeting attendees. Be sure to stop by and view the exhibition. This multimedia event includes oil and acrylic paintings, watercolors, sculpture, photography, woodcarvings, ceramics, calligraphy paintings, pottery, woodcuts, wood burning and lithography.

View the artistic talents of your colleagues!

“The most beautiful experience we can have is the mysterious — the fundamental emotion which stands at the

cradle of true art and true science.”

~ Albert Einstein

Page 40: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

40 www.asdp.org/AM16 #ASDP2016

Short Course IIIEverything You Always Wanted to Know About Nails But Were Afraid to AskSaturday, October 298:00 a.m. – 12:15 p.m.Grand Ballroom, 2nd Floor

Course Director:Beth S . Ruben, MDPalo Alto Medical Foundation

3.5 AMA PRA Category 1 CreditsTM 3.5 AAD Recognized Credit

In this nail marathon, a panel of dermatopathologists with special interest and expertise in diagnostic pathology of the nail unit will present a broad range of related topics . This will include basic nail anatomy and surgical techniques as well as optimal submission and processing of nail specimens, including tricks of the trade . An intensive discussion of inflammatory and neoplastic conditions, including melanocytic, will follow with attention to clinicopathologic correlation . The goal of this session is for participants to build a solid base of knowledge in this often unfamiliar area of dermatology and dermatopathology, to be able to interpret these specimens with more confidence.

Faculty and Course Outline8:00 a .m . – 8:05 a .m . Introduction Beth S . Ruben, MD Palo Alto Medical Foundation

8:05 a .m . – 8:40 a .m . Nail Unit Anatomy/Histology and Surgical Techniques Adam I . Rubin, MD University of Pennsylvania

8:40 a .m . – 9:10 a .m . Optimal Handling and Processing of Nail Specimens Curtis T . Thompson, MD CTA Lab

9:10 a .m . – 9:45 a .m . Inflammatory and Infectious Diseases of the Nail Unit Molly A . Hinshaw, MD University of Wisconsin, Madison

9:45 a .m . – 10:00 a .m . Q&A

10:00 a .m . – 10:45 a .m . Refreshment Break

Plenary Program (continued)

Page 41: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 41

10:45 a .m . – 11:25 a .m . Melanonychia and Melanocytic Neoplasms Josette André, MD CHU Saint-Pierre

11:25 a .m . – 12:00 p .m . Epithelial and Other Select Neoplasms of the Nail Unit Beth S . Ruben, MD Palo Alto Medical Foundation

12:00 p .m . – 12:15 p .m . Q&A

Upon completion of this course, participants should be able to: ➜ Diagnose inflammatory and neoplastic conditions, including melanocytic, with

confidence.

➜ Build a solid base of skills in diagnostic pathology of the nail unit .

➜ Become proficient at basic nail anatomy and the surgical techniques leading to nail specimens .

➜ Develop practical skills in nail specimen submission and processing .

➜ Identify a broad range of dermatopathologic inflammatory and neoplastic conditions affecting the nail unit.

Satu

rday

, O

ctob

er 2

9

Page 42: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

42 www.asdp.org/AM16 #ASDP2016

Fellows’ PresentationsSaturday, October 292:00 p.m. – 4:00 p.m.Grand Ballroom, 2nd Floor

Course Moderator:Sara Shalin, MD, PhDUniversity of Arkansas for Medical Sciences

2 AMA PRA Category 1 CreditsTM 2 AAD Recognized Credit

The Continuing Education and Research Committee has selected 18 of the outstanding submissions in the Fellows in Dermatopathology abstract category to be presented orally . Abstract session will have a mix of case reports, clinical studies and basic science presentations . Abstracts presented in Fellows’ Presentations can be found in the abstract PDF book available for download at www .asdp .org/AM16 . Abstracts are listed in order of presentation .

Time Title Speaker2:00 p .m . – 2:05 p .m . Metastatic Malignant Melanoma

with Gains of Chromosome Region 22q12 by FISH

Ryan S . Berry, MD

2:05 p .m . – 2:10 p .m . Libman-Sacks Endocarditis Presenting as an Initial Symptom of Systemic Lupus Erythematosus

Jose E . Ollague, MD

2:10 p .m . – 2:15 p .m . Non-blistering PD-1 inhibitor- induced Bullous Pemphigoid: Entering an Era of Autoimmune Disorders Induced by Checkpoint Blockade

Katherine Roy, MD

2:15 p .m . – 2:20 p .m . EBV-associated, Cutaneous, Smooth Muscle Tumor in AIDS Patient

Yevgeniya B . Rainwater, MD

2:20 p .m . – 2:25 p .m . Fibroblastic Rheumatism: A Rare But Pertinent Dermatoarthropathy

Justin P . Bandino, MD

Plenary Program (continued)

Page 43: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 43

2:25 p .m . – 2:30 p .m . Nodular Cutaneous Microsporidiosis in an Immunocompromised Patient

Emily H . Smith, MD

2:30 p .m . – 2:35 p .m . A Subset of Melanocytic Nevi with Sclerosing and Epithelioid Features and Consistent Gain of Chromosome 15: A New Subtype of Spitz Nevus?

John Scopetta, MD

2:35 p .m . – 2:40 p .m . Amyloidoma of the Skin/Subcutis with Monotypic Plasma Cell Infiltrates: An Unusual Presentation of Primary Cutaneous Marginal Zone Lymphoma?

Ian Marie L . Lano, MD

2:40 p .m . – 2:45 p .m . T-cell Acute Lymphoblastic Lymphoma/Leukemia Presenting as a Diffuse Exanthem: A Clinical and Histopathologic Challenge

Jessica M . Kwock, MD

2:45 p .m . – 2:50 p .m . ALK1-positive Pediatric Spitzoid Melanoma with Homozygous Deletion of 9p21 (CDKN2A) and Gain of 6p25 (RREB1) by FISH: A Case Report

Andrew J . Rand, MD

2:50 p .m . – 2:55 p .m . A Primary Cutaneous Burkitt Lymphoma with Classic Immunohistochemical and Molecular Findings

Aravindhan Sriharan, MD

2:55 p .m . – 3:00 p .m . Epithelioid Fibrous Histiocytoma with Collagen Rosettes

Stephanie J .T . Chen, MD

3:00 p .m . – 3:10 p .m . An Evaluation of the Utility of a Novel Microsatellite Instability Assay in the Workup of Sebaceous Neoplasms

Jay Wofford, MD

3:10 p .m . – 3:20 p .m . Utility of Histologic Features of Secondary Syphilis

Alexandra Flamm, MD

3:20 p .m . – 3:30 p .m . Expression of Metallopanstimulin-1 in the Spectrum of Melanocytic Neoplasms

Maria A . Deschaine, MD

3:30 p .m . – 3:40 p .m . STAT3 Gene Mutation and Enhanced STAT3 Phosphorylation is Detected in a Subset of Tumor Stage Mycosis Fungoides with Large Cell Transformation

Andy C . Hsi, MD

Satu

rday

, O

ctob

er 2

9

Page 44: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

44 www.asdp.org/AM16 #ASDP2016

3:40 p .m . – 3:50 p .m . Histopathologic Attributes Associated with MelaFind Classification: A 3-Year Experience with High-Risk Pigmented Lesion Clinic

Vikas Shrivastava, MD

3:50 p .m . – 4:00 p .m . The Ciliation Index Distinguishes Invasive Melanoma and Melanoma In-Situ from Associated Dermal Melanocytic Nevi

Ursula E . Lang, MD, PhD

Upon completion of this session, participants should be able to: ➜ Identify various clinical and basic science topics within dermatopathology .

➜ Exemplify and promote the exchange of new ideas and concepts within the field of dermatopathology .

➜ Describe innovative investigative studies and tools pertaining to bench and translational research .

➜ Compare unique pathological perspectives and concepts as they relate to individual and groups of cases .

Plenary Program (continued)Fellows’ Presentations (continued)

Page 45: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 45

2016 President’s AddressSaturday, October 294:30 p.m. – 5:00 p.m.International Ballroom North, 2nd Floor

.5 AMA PRA Category 1 CreditTM

.5 AAD Recognized Credit

Dirk M. Elston, MD

Simple Techniques You May Not be Using and How We Use Criteria

We make diagnoses every day based upon histological criteria, but there has been little study of the statistical validity of those criteria . It is time to take a fresh look at the criteria we use and how they stand up to scrutiny . We will also look at some simple techniques that can be applied in practice to assist with diagnosis .

Upon completion of this lecture, participants should be able to: ➜ Demonstrate effective use of EVG staining, polarization and diffraction.

➜ Identify relevant criteria in syphilis, melanoma and keratoacanthoma diagnoses .

Satu

rday

, O

ctob

er 2

9

Page 46: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

46 www.asdp.org/AM16 #ASDP2016

Congratulations to the 2016 Dermatopathology Research Career

Development Award Recipients

Emily Y. Chu, MD, PhD – Year 3University of PennsylvaniaIdentification of Molecular Prognostic Markers for Thin Melnoma

Julia S. Lehman, MD – Year 2 Mayo Clinic, Rochester Discovery and Validation of Tissue-based Biomarkers of Acute Graft-versus-host Disease of the Skin

Karolyn A. Wanat, MD – Year 2University of IowaPathogenesis of Cutaneous Leishmaniasis: Role of Mast Cells and Eosinophils

The Dermatopathology Research Career Development Award is administered by the Dermatology Foundation.

www.dermatologyfoundation.org

Plenary Program (continued)

Page 47: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 47

2016 Elson B. Helwig Memorial LectureSaturday, October 295:00 p.m. – 6:00 p.m. International Ballroom North, 2nd Floor

1 AMA PRA Category 1 CreditsTM

1 AAD Recognized Credit

The Elson B . Helwig Memorial lectureship is awarded in recognition of excellence in the realm of diagnostic dermatopathology and for significant contribution to the dermatopa-thology literature and the education of fellows and colleagues .

Sharon W. Weiss, MDProfessor of Pathology and Laboratory MedicineEmory University Hospital Associate Dean for Faculty Affairs Emerita Emory University School of Medicine

Vascular Tumors: Our Changing ConceptsMajor conceptual shifts have occurred in our understanding of vascular tumors over the last few decades . These include emergence of the category of borderline vascular tumors (hemangioendothelioma) and an appreciation of the morphologic and molecular diversity of angiosarcomas . This lecture will trace the

evolution of these concepts and feature important new entities illustrative of these changes .

Upon completion of this course, participants should be able to:

➜ Identify diagnostic criteria for selected vascular neoplasms .

➜ Develop a practical approach to the evaluation and diagnosis of cutaneous vascular tumors .

➜ Apply appropriate ancillary tests in the evaluation of vascular tumors, emphasizing a practical and cost-effective approach.

This clinically oriented lecture began in October 1998 as the “Special Guest Lecture .” On July 31, 2000, the “Special Guest Lecture” was officially named the Elson B. Helwig Memorial Lecture in tribute of Dr . Helwig .

Visit www.asdp.org/helwig for a list of previous Elson B. Helwig Memorial Lecturers.

Satu

rday

, O

ctob

er 2

9

Page 48: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

48 www.asdp.org/AM16 #ASDP2016

Evening Slide SymposiumWith Audience Response System

Saturday, October 296:00 p.m. – 9:00 p.m.International Ballroom North, 2nd Floor

Course Director:Melissa Pulitzer, MDMemorial Sloan Kettering Cancer Center

3.5 AMA PRA Category 1 CreditsTM

3.5 AAD Recognized Credit30 MOC SA Question Credits

In this traditionally popular symposium, a six-member panel will present 18 microscopi-cally challenging cases . An in-depth discussion by the panel will focus on the histological and clinicopathological aspects of each case . A relaxed and educationally stimulating atmosphere is planned . Audience participation is encouraged, via an audience response system, and casual attire is expected . Complimentary soda and snacks will be served .

FacultyPedram Gerami, BS, MDNorthwestern University, Feinberg School of Medicine

Alejandro A. Gru, MDUniversity of Virginia

Jennifer S . Ko, MDCleveland Clinic

Melissa Pulitzer, MDMemorial Sloan Kettering Cancer Center

Leonard C . Sperling, MDUniformed Service University of the Health Sciences

Carlos Torres-Cabala, MDThe University of Texas MD Anderson Cancer Center

Upon completion of this course, participants should be able to:

➜ Demonstrate different approaches toward diagnosis of various challenging skin biopsies .

➜ Generate clinically relevant differential diagnoses.

➜ Differentiate clinical and histological features of interesting, difficult and rare disorders of the skin .

Plenary Program (continued)

Page 49: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 49

Evening Slide Symposium Case Summaries

Case 1A lesion from midline back of a 6-day-old female who is otherwise healthy .

Case 2A newly developed 3mm translucent papule on the lip of a 13-year-old boy; clinical impression from an experienced pediatric dermatologist was mucocele . Labels positive for S100 .

Case 3A 2-week-old child with giant congenital nevus with several growing nodules . FISH and CGH testing showed multiple whole chromosomal gains and losses but without any segmental gains or losses .

Case 4A 69-year-old woman presented with a nodule on the upper back .

Case 5A 36-year-old woman presented with a 3cm variably pigmented plaque on the upper back .

Case 6A 60-year-old woman presented with a 4cm plaque on the right breast .

Case 7 A 65-year-old man presented with a spot on his left upper arm. He noticed the lesion for about 6 months; it kept getting bigger and darker and started to bleed.

Case 8A 76-year-old man presented with a lesion on his frontal scalp that was biopsied . New lesions appeared two months later in the same anatomic area .

Case 9A 49-year-old man presented with a history of two lesions on his forehead that were treat-ed with local excision and radiation. He now presents with five new lesions distributed on his face (post auricular area and forehead) .

Case 10A 50-year-old female with a history of mycosis fungoides presents with new calf nodules .

Case 11A 72-year-old man with persistent and slowly progressing cutaneous nodules, new ret-ro-auricular tumor and lymphadenopathy on PET scan .

Satu

rday

, O

ctob

er 2

9

Page 50: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

50 www.asdp.org/AM16 #ASDP2016

Case 12A 43-year-old male jeweler with bilateral conjunctival pigmentation increasing in size over 5 year period .

Case 13A 4-year-old Caucasian girl presented for evaluation of sparse brittle hair and develop-mental delay .

Case 14The patient is a 32-year-old white male complaining of patches of hair thinning on the scalp .

Case 15A 72-year-old Asian female with a history of microscopic polyangiitis on rituximab and chronic prednisone . Has had multiple hospital admissions, now in ICU for steady neuro-logic decline and numerous dusky, indurated skin nodules on the thigh .

Case 16A 76-year-old man presents with a rapid onset of widespread ulcerated plaques, nodules and large tumors on the trunk and head and neck area . PET-CT scan shows disease limit-ed to the skin, without evidence of lymph node, liver or splenic involvement . The patient endorses no history of previous lymphoma .

Case 17A 54-year-old woman presents with nodules and plaques in the eyelids, malar region and upper extremities . She also reports occasional symptoms of night fevers, sweating and chills .

Case 18A 1-year-old boy presents with multiple partially blanching vascular plaques in a linear distribution on the posterior leg .

Plenary Program (continued)Evening Slide Symposium (continued)

Page 51: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 51

53rd Annual Meeting Evening Slide SymposiumEarn SAMs or MOC SA Question Credits!Additional Fee and Post Course Registration Required

3.5 SAMs50 MOC SA Question CreditsVisit www.asdp.org/2016ESS for more information.

Satu

rday

, O

ctob

er 2

9

SAVE THE DATES!ASDP 54th Annual Meeting

October 26–29, 2017

Marriott Baltimore Waterfront Hotel

Baltimore, Maryland USA

ASDP 55th Annual Meeting

November 8–12, 2018

Hilton Chicago

Chicago, Illinois USA

Page 52: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

52 www.asdp.org/AM16 #ASDP2016

Oral Abstract Session 3Sunday, October 307:30 a.m. – 8:30 a.m.Grand Ballroom, 2nd Floor

Course Moderator:Michael T. Tetzlaff, MD, PhDMD Anderson Cancer Center

1 AMA PRA Category 1 CreditsTM

1 AAD Recognized Credit

Abstracts presented in Oral Abstract Session 3 can be found in the abstract PDF book available for download at www .asdp .org/AM16 . Abstracts are listed in the order of presentation .

Time Title Speaker7:30 a .m . – 7:40 a .m . Fontana-Masson Stain in

Fungal InfectionsPuja K . Puri, MD

7:40 a .m . – 7:50 a .m . Adipophilin Expression in Cutaneous Malignant Melanoma

Masakazu Fujimoto, MD, PhD

7:50 a .m . – 8:00 a .m . Can Mass Spectrometry Imaging Predict the Clinical Behavior of Atypical Melanocytic Neoplasms?

Rossitza Lazova, MD

8:00 a .m . – 8:10 a .m . Correlation Between Human Papillomavirus Status on Condylomata in Women and Risk of Cervical Dysplasia on Papanicolaou Smear: A Case-control Study

Julia S . Lehman, MD

8:10 a .m . – 8:20 a .m . Immunological Characterization of Sentinel Lymph Nodes Involved by Metastatic Melanoma

James J . Abbott, BS

Plenary Program (continued)

Page 53: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 53

8:20 a .m . – 8:30 a .m . Gene Expression Signature as an Ancillary Method in the Diagnosis of Desmoplastic Melanoma

Loren E . Clarke, MD

Upon completion of these sessions, participants should be able to:

➜ Identify various clinical and basic science topics within dermatopathology .

➜ Exemplify and promote exchange of new ideas and concepts within the field of dermatopathology .

➜ Describe innovative investigative studies and tools pertaining to bench and translational research .

➜ Compare unique pathological perspectives and concepts as they relate to individual and groups of cases .

Sund

ay,

Oct

ober

30

Page 54: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

54 www.asdp.org/AM16 #ASDP2016

Short Course IVUpdate in Cutaneous LymphomaSunday, October 308:45 a.m. – NoonGrand Ballroom, 2nd Floor

Course Director:Tammie C . Ferringer, MDGeisinger Medical Center

3.25 AMA PRA Category 1 CreditsTM

3.25 AAD Recognized Credit

Dermatopathologists are faced with differentiation of cutaneous lymphomas from sys-temic lymphoma involving the skin and non-lymphoma mimics . This course will focus on an organized approach to this heterogeneous group. Recent advances in classification, immunophenotypic and molecular analysis will be addressed .

Faculty and Course Outline8:45 a .m . – 8:50 a .m . Introduction Tammie C . Ferringer, MD Geisinger Medical Center

8:50 a .m . – 9:15 a .m . Algorithmic Approach to Cutaneous Lymphoma Antonio Subtil, MD, MBA Yale University

9:15 a .m . – 9:40 a .m . Cutaneous B-Cell Lymphoma: From IHC to Molecular Joan Guitart, MD Northwestern University

9:40 a .m . – 10:05 a .m . Cutaneous T-Cell Lymphoma: From IHC to Molecular Jinah Kim, MD, PhD Stanford University

10:05 a .m . – 10:30 a .m . Cutaneous Lymphoma Mimics Lyn M . Duncan, MD Massachusetts General Hospital

Plenary Program (continued)

Page 55: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 55

10:30 a .m . – 10:55 a .m . Provisional and Unspecified Lymphomas Alistair M . Robson, MD St. John’s Institute of Dermatology, St. Thomas’ Hospital,

London, UK

10:55 a .m . – 11:20 a .m . CD30 Everywhere? Werner Kempf, MD Kempf und Pfaltz Histologische Diagnostik, Switzerland

11:20 a .m . – 11:45 a .m . Tough Spots David J . DiCaudo, MD Mayo Clinic, Scottsdale

11:45 – Noon Q&A

Upon completion of this course, participants should be able to:

➜ Recognize and differentiate the multiple types of cutaneous lymphoma.

➜ Apply appropriate immunohistochemistry and clonality studies to cutaneous lymphoma diagnoses .

Opt

iona

l Cou

rses

&

Even

ts

Page 56: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

56 www.asdp.org/AM16 #ASDP2016

Optional Courses & EventsConsultations in Dermatopathology1.25 AMA PRA Category 1 CreditsTM per course1.25 AAD Recognized Credit per course

Tickets are required to enter each course.

All Consultations in Dermatopathology rooms are located on the 3rd Floor.All courses use a 10-headed microscope with a class size of nine . Generally, each session permits 30 minutes of study at individual microscopes followed by 45 minutes of interactive work with the course director .

Thursday, October 279:00 a.m. – 10:15 a.m.

100 Jinah Kim, MD, PhD Adventures in Cutaneous Lymphoma: My Cases and Yours

PDR #1

101 David S . Cassarino, MD, PhD Atypical and Malignant Adnexal Neoplasms PDR #2

102 Patrick O . Emanuel, MBChB,Dip Arts

High-risk Non-melanoma Skin Carcinomas – Cases from UV-drenched New Zealand

PDR #3

10:45 a.m. – Noon

103 Raymond L . Barnhill, MD The Difficult Melanocytic Lesion PDR #1

104 Pedram Gerami, BS, MD Understanding and Interpreting FISH Results Including the Pitfalls When Evaluating Melanocytic Neoplasms

PDR #2

105 Loren E . Golitz, MD Pediatric Dermatopathology PDR #3

1:00 p.m. – 2:15 p.m.

106 Mai P . Hoang, MD Role of Immunohistochemistry in Diagnosing Tumors of Cutaneous Appendages

PDR #1

107 Adam I . Rubin, MD Basic and Advanced Nail Pathology PDR #2

108 Doina Ivan, MD Cutaneous Adnexal Tumors: A Practical Reappraisal of Immunohistochemical Use

PDR #3

2:45 p.m. – 4:00 p.m.

109 Dirk M . Elston, MD Tough Melanocytic Lesions PDR #1

110 Vesna Petronic-Rosic, MD, MSc Histopathologic Diagnosis of Granulomatous Diseases

PDR #2

111 Laszlo J . Karai, MD, PhD CD30 Positive Primary Cutaneous Lymphoid Proliferations: “Making Sense of the Alphabet Soup”

PDR #3

Page 57: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 57

Opt

iona

l Cou

rses

&

Even

ts

4:30 p.m. – 5:45 p.m.

112 Mai P . Hoang, MD Role of Immunohistochemistry in Detecting Molecular Abnormalities

PDR #1

113 Christine G . Lian, MD New IHC Genetic and Epigenetic Biomarkers in Evaluating Difficult Melanocytic Lesions

PDR #2

114 Rajiv M . Patel, MD A Practical Pattern-based Approach to Cutaneous Soft Tissue Tumors

PDR #3

Friday, October 287:00 a.m. – 8:15 a.m.

200 Steven D . Billings, MD Diagnostic Challenges in Cutaneous Soft Tissue Tumors

PDR #1

201 Artur Zembowicz, MD, PhD Ophthalmic Pathology for Dermatopathologists: Pitfalls in Pathology of the Eyelid and Conjunctiva (Part I): Melanocytic Lesions

PDR #2

202 Hideko Kamino, MD Challenging Fibrohistiocytic Proliferations

PDR #3

8:45 a.m. – 10:00 a.m.

203 Artur Zembowicz, MD, PhD Ophthalmic Pathology for Dermatopathologists: Pitfalls in Pathology of the Eyelid and Conjunctiva (Part II): Adnexal Neoplasms

PDR #1

204 Lynn D . Cooper, MD A Fundamental/Algorithmic Approach to Atypical Lymphoid Infiltrates: Benign vs. Malignant

PDR #2

205 Lynne J . Goldberg, MD Approach to the Alopecia Biopsy PDR #3

10:30 a.m. – 11:45 a.m.

206 Leonard C . Sperling, MD Advanced Alopecia PDR #1

207 Lynn D . Cooper, MD A Fundamental/Algorithmic Approach to Atypical Lymphoid Infiltrates: Benign vs. Malignant

PDR #2

208 Omar P . Sangueza, MD Vascular Lesions PDR #3

Page 58: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

58 www.asdp.org/AM16 #ASDP2016

1:30 p.m. – 2:45 p.m.

209 Maxwell A . Fung, MD Panniculitis and Other Puzzles PDR #1

210 Catherine M . Stefanato, MD, FRCPAth

Alopecia Pitfalls PDR #2

211 Laura B . Pincus, MD Instructive Cases from the UCSF Cutaneous Lymphoma Clinic

PDR #3

3:15 p.m. – 4:30 p.m.

212 Alina G . Bridges, DO Challenging Inflammatory Dermatopathology

PDR #1

213 Beth S . Ruben, MD Nail Pathology: Basics and Beyond PDR #2

214 M . Angelica Selim, MD Current Issues in Vulvar Pathology PDR #3

5:00 p.m. – 6:15 p.m.

215 Zsolt B . Argenyi, MD Diagnostic Approach to Problematic Neural Tumors

PDR #1

216 Lyn M . Duncan, MD Cutaneous Lymphoma or Not PDR #2

217 Adam I . Rubin, MD Pediatric Dermatopathology: Instructive Cases From The Children’s Hospital of Philadelphia

PDR #3

Saturday, October 297:00 a.m. – 8:15 a.m.

300 Steven D . Billings, MD Diagnostic Challenges in Cutaneous Soft Tissue Tumors

PDR #1

301 David J . DiCaudo, MD Cutaneous Lymphomas PDR #2

302 Richard C . Jordan, DDS, PhD, FRCPath

Oral Pathology Roundtable Review: Common, Uncommon and Challenging Cases

PDR #3

8:45 a.m. – 10:00 a.m.

303 Richard C . Jordan, DDS, PhD, FRCPath

Oral Pathology Roundtable Review: Common, Uncommon and Challenging Cases

PDR #1

304 Lynne J . Goldberg, MD Approach to the Alopecia Biopsy PDR #2

305 M . Angelica Selim, MD Current Issues in Vulvar Pathology PDR #3

Optional Courses & Events (continued)Consultations in Dermatopathology (continued)

Page 59: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Opt

iona

l Cou

rses

&

Even

ts

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 59

10:45 a.m. – Noon

306 Antonio Subtil, MD, MBA Cutaneous B-Cell Lymphoma (CBCL) PDR #1

307 Daniel D . Miller, MD Quandaries in Hospital Inpatient Dermatopathology

PDR #2

308 Leonard C . Sperling, MD Advanced Alopecia PDR #3

1:45 p.m. – 3:00 p.m.

309 David J . DiCaudo, MD Look-alikes in Neoplastic Dermatopathology

PDR #1

310 Eleanor A . Knopp, MD Basic Alopecia PDR #2

311 Jerad M . Gardner, MD 7 Deadly Sins: 7 Cutaneous Soft Tissue Tumors You Never Want to Miss

PDR #3

6:00 p.m. – 7:15 p.m.

312 Philip E . LeBoit, MD Lessons I Have Learned From Difficult Cases PDR #1

313 Timothy H . McCalmont, MD Cutaneous Spindle Cell Lesions by Light and IPX

PDR #2

314 Dirk M . Elston, MD Infections and Infestations PDR #3

Sunday, October 307:00 a.m. – 8:15 a.m.

400 Melissa Pulitzer, MD Signs and Signals for Decoding Cutaneous Hematolymphoid Disease

PDR #1

401 Catherine M . Stefanato, MD, FRCPath

Alopecia Pitfalls PDR #2

402 Timothy H . McCalmont, MD Cutaneous Spindle Cell Lesions by Light and IPX

PDR #3

8:45 a.m. – 10:00 a.m.

403 Philip E . LeBoit, MD Lessons I Have Learned From Difficult Cases PDR #1

404 Maxwell A . Fung, MD Panniculitis and Other Puzzles PDR #2

405 Beth S . Ruben, MD Nail Pathology: Basics and Beyond PDR #3

10:30 a.m. – 11:45 a.m.

406 Rajiv M . Patel, MD A Practical Pattern-based Approach to Cutaneous Soft Tissue Tumors

PDR #1

407 Pedram Gerami, BS, MD Understanding and Interpreting FISH Results Including the Pitfalls When Evaluating Melanocytic Neoplasms

PDR #2

408 Clay J . Cockerell, MD Challenging Clinicopathologic Correlations

PDR #3

Page 60: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

60 www.asdp.org/AM16 #ASDP2016

Mini CourseAlopecia: Step-by-StepThursday, October 279:00 a.m. – NoonGrand Ballroom, 2nd Floor

3 AMA PRA Category 1 CreditsTM

3 AAD Recognized Credit

Course Director:Leonard C . Sperling, MD Uniformed Services University of the Health Sciences

This year’s mini course will provide an overview of the histologic interpretation of alopecia with clinical correlation . The course will also cover tissue processing, an approach to an organized microscopic evaluation, key histologic features and their diagnostic significance, review of non-cicatricial alopecia and cicatricial alopecia, and clinical/pathologic correlation .

Faculty and Course Outline9:00 a .m . – 9:10 a .m . Introductions Leonard C . Sperling, MD Uniformed Services University of the Health Sciences

9:10 a .m . – 9:40 a .m . Transverse (Horizontal) Versus Vertical Sections: The Ups, the Downs and the Sideways Lynne J . Goldberg, MD Boston University School of Medicine

9:40 a .m . – 10:10 a .m . The Step-by-Step Method for Evaluating the Biopsy Eleanor A . Knopp, MD Group Health Permanente and University of Washington

10:10 a .m . – 10:40 a .m . Non-cicatricial Alopecia Catherine M . Stefanato, MD, FRCPath St. John’s Institute of Dermatology, St. Thomas’ Hospital,

London, UK

10:40 a .m . – 11:10 a .m . Cicatricial Alopecia Shawn E . Cowper, MD Yale University School of Medicine

Optional Courses & Events (continued)

Page 61: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Opt

iona

l Cou

rses

&

Even

ts

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 61

11:10 a .m . – 11:40 a .m . Clinical/Pathologic Correlation: A Team Sport Leonard C . Sperling, MD Uniformed Services University of the Health Sciences

11:40 a .m . – Noon Panel Discussion: Tips and Pearls

Upon completion of this course, participants should be able to:

➜ Utilize a step-by-step approach to the histologic evaluation of hair loss .

➜ Select appropriate technique for sectioning the “alopecia” biopsy specimen .

➜ Recognize the role and responsibilities of the clinician in the interpretation of an “alopecia” biopsy specimen .

Page 62: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

62 www.asdp.org/AM16 #ASDP2016

Self-Assessment in DermatopathologyCourse Director:Ronald P . Rapini, MDUniversity of Texas Houston Medical School and the University of Texas MD Anderson Cancer Center

6.5 AMA PRA Category 1 CreditsTM

6.5 AAD Recognized Credits6.5 SAMs100 MOC SA Question Credits

Be on time – Self-Assessment sessions begin on time . Due to the timed schedule of each session, doors will close promptly at start time . Late arrivals will not be permitted . No refunds will be given for sessions missed due to tardiness . No exceptions.

Participants will have the opportunity to study 50 challenging slides representing a wide range of inflammatory and neoplastic diseases during one of four identical sessions (A, B, C or D) . Subsequently, all participants will meet in a single Self-Assessment Discussion session in which faculty members will review the diagnostic features of each case, as well as the differential diagnosis. You must be registered for one of the Thursday or Friday slide viewing sessions (A, B, C or D) to attend the Discussion session . Separate tickets are required to enter each course .

The Self-Assessment Case Answers and Discussions book is only available online; printed books are not distributed at the meeting . Self-Assessment participants will receive an email with a link to download the Self-Assessment Case Answers and Discussions book upon con-clusion of the Self-Assessment Discussion Friday evening . The Self-Assessment Slide Viewing Questions book will continue to be distributed prior to each slide viewing session .

Post-course online self-assessment: A post-course online self-assessment will be available after the meeting and will include 25 core knowledge cases in addition to the 50 advanced cases studied at the meeting . Registrants must take the post-course online self-assessment in order to claim SAMs or MOC SA question credits . Self-assessment regis-trants will receive a link to the post-course online self-assessment by email approximately two to three weeks after the Annual Meeting and will have up to 30 days to complete the activity . Self-Assessment participants must take the post-course online self-assessment to receive MOC credit for this activity .

CME – Participants will receive 2 Category 1 CME Credits™ for one of the Self-Assessments A-D, 3 .5 Category 1 CME Credits™ for the Self-Assessment Discussion and 1 Category 1 CME Credit™ for completion of the post-course online self-assessment for a total of 6 .5 Category 1 CME Credits™. Participants must complete the post-course online self-assess-

Optional Courses & Events (continued)

Page 63: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Opt

iona

l Cou

rses

&

Even

ts

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 63

ment with a score of 60 percent or better in order to claim the remaining CME credit . A CME certificate will be available to print after completing the meeting evaluation online.

MOC – The ASDP Annual Meeting Online Post-course Self-Assessment offers MOC self-as-sessment credits to satisfy the American Board of Dermatology (ABD) Component 2 and the American Board of Pathology (ABP) Part II MOC requirements. A MOC certificate will be available to print upon successful completion of the online past-course self-assessment .

ABD SA – The ASDP has been approved by the American Board of Dermatology (ABD) to produce Self-Assessment (SA) activities to satisfy the ABD Maintenance of Certification program Component 2. SA activities are intended to be of value to the practicing dermatologist . ASDP is solely responsible for the content . The ASDP SA in Dermatopathology offers up to 100 MOC SA question credits. Participants must take the post-course online self-assessment in order to claim SA points .

ABP SAMs – ASDP is a provider of Self-Assessment Modules (SAMs) for Part II of the Maintenance of Certification program of the American Board of Pathology (ABP). The ASDP Self-Assessment in Dermatopathology offers six and a half (6.5) SAMs. Participants must take and pass the post-course online self-assessment with a score of 60 percent or better in order to claim SAMs, and may take the self-assessment as many times as needed to achieve a passing score .

FacultyPhyu Aung, MD, PhD, FACPThe University of Texas MD Anderson Cancer Center

Alma C . Berlingeri, MDThe University of Texas Medical Branch

April C . Deng, MDUniversity of Massachusetts

Carrie L . Kovarik, MD University of Pennsylvania

Vincent Liu, MD University of Iowa Hospitals & Clinics

Anisha B . Patel, MD The University of Texas Houston and the University of Texas MD Anderson

Cancer CenterSara B . Peters, MD The Ohio State University

Ronald P . Rapini, MD The University of Texas Houston Medical School and the University of Texas MD Anderson Cancer Center

Kerri E . Rieger, MD, PhD Stanford University School of Medicine

Arlene Ruiz De Luzuriaga, MD The University of Chicago

Janis M . Taube, MD John Hopkins Hospital

Page 64: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

64 www.asdp.org/AM16 #ASDP2016

ScheduleThursday, October 271:00 p .m . – 3:00 p .m . Session A Williford B/C, 3rd Floor (Note: This session conflicts with Consultations 106, 107, 108, 109, 110 and 111)

4:00 p .m . – 6:00 p .m . Session B Williford B/C, 3rd Floor (Note: This session conflicts with Consultations 112, 113 and 114)

Friday, October 287:00 a .m . – 9:00 a .m . Session C Williford B/C, 3rd Floor (Note: This session conflicts with Consultations 200, 201, 202, 203, 204 and 205)

10:00 a .m . – Noon Session D Williford B/C, 3rd Floor (Note: This session conflicts with Consultations 206, 207, 208)

2:00 p .m . – 6:15 p .m . Self-Assessment International Ballroom North, Discussion 2nd Floor (Note: This session conflicts with Consultations 209, 210, 211, 212, 213, 214, 215, 216 and 217)

Upon completion of this course, participants should be able to: ➜ Differentiate between diseases with similar or overlapping histopathologic findings.

➜ Expand diagnostic skills by increasing familiarity with a variety of skin conditions .

➜ Recognize key light microscopic features of common, rare and unusual entities .

➜ Incorporate new information gained from the presented cases into dermatopathology practice .

➜ Modify existing comfort level with the more common cases likely to be seen in daily practice .

➜ Recognize areas where new information gained from the presented cases has identified potential practice gaps and altered performance related to the presented cases .

Optional Courses & Events (continued)Self-Assessment in Dermatopathology (continued)

Page 65: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Opt

iona

l Cou

rses

&

Even

ts

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 65

President’s Reception & BanquetDirk M . Elston, MD, President

Friday, October 287:00 p.m. – 11:00 p.m.Hilton Chicago International Ballroom South, 2nd Floor

Join ASDP President Dirk M . Elston, MD for the President’s Reception and Banquet, an elegant evening of dinner and socializing with colleagues .

Hilton Chicago’s International Ballroom was built and opened in 1962 . At the time it was the world’s largest

ballroom at 22,000 square feet and freestanding of any pillars. This was part of an effort by Conrad Hilton himself to ensure this hotel was the largest not only in terms of guest rooms but also in terms of meeting and convention facilities .

Page 66: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

66 www.asdp.org/AM16 #ASDP2016

Meet the Program DirectorsSaturday, October 296:45 a.m. – 8:00 a.m.Boulevard, 2nd Floor

Are you a dermatology or pathology resident and thinking of applying for a dermatopathology fellowship?

During this session, trainees will have an opportunity to meet program directors from across the country . Participants will move from table to table in a “speed dating” format, allowing all attendees to spend time with multiple program directors . Attend this session and enjoy your morning coffee with your future program director.

This session is open to dermatology and pathology residents only. There’s no fee to attend, but registration is required. Seats may still be available — visit the onsite registration desk for more information.

Optional Courses & Events (continued)

SAVE THE DATES! 4th and 5th Annual ASDP Essentials of

Dermatopathology MOC & Board Review CoursesJW Marriott Houston Downtown

Houston, TX USA

April 28 – 30, 2017 May 18 – 20, 2018

Earn CME, MOC SA and SAM credits. Questions? Contact ASDP at +1-847-686-2231

Or [email protected] for more information.

Essentials of Dermatopathology Board Review & MOC Course

Page 67: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 67

CME Attendance LogThe American Society of Dermatopathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians . ASDP designates this live activity for a maximum of 35 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity .

This form is for your personal tracking only.Official CME claims are completed online.

Course Maxiumum Hours (35) Hours Claimed

Thursday, October 27, 2016Mini Course – Alopecia: Step-by-Step 9:00 a .m . – Noon 3 _______________Consultations in Dermatopathology (Courses 100-114) ___x 1 .25 each _______________Short Course I 1:00 p .m . – 3:15 p .m . 2 .25 _______________Oral Abstract Session 1 3:45 p .m . – 5:15 p .m . 1 .5 _______________Duel in Dermatopathology 5:15 p .m . – 6:45 p .m . 1 .5 _______________Future Directions in Dermatopathology 7:00 p .m . – 9:00 p .m . 2 _______________Self-Assessment (A or B) 2 each _______________

Friday, October 28, 2016Consultations in Dermatopathology (Courses 200-217) ___x 1 .25 each _______________ Short Course II 8:00 a .m . – Noon 3 .5 _______________Oral Abstract Session 2 1:30 p .m . – 3:00 p .m . 1 .5 _______________Self-Assessment (C or D) 2 each _______________Self-Assessment Discussion 2:00 p .m . – 6:15 p .m . 3 .5 _______________Pinkus Basic Science Course 3:15 p .m . – 6:30 p .m . 2 .5 _______________Poster Session 1 Defense 4:15 p .m . – 5:00 p .m . .75 _______________

Saturday, October 29, 2016Consultations in Dermatopathology (Courses 300-314) ___x 1 .25 each _______________ Short Course III 8:00 a .m . – 12:15 p .m . 3 .5 _______________Poster Session 2 Defense 10:00 a .m . – 10:45 a .m . .75 _______________Fellows’ Presentations 2:00 p .m . – 4:00 p .m . 2 _______________President’s Address 4:30 p .m . – 5:00 p .m . .5 _______________Helwig Lecture – S . Weiss 5:00 p .m . – 6:00 p .m . 1 _______________Evening Slide Symposium 6:00 p .m . – 9:00 p .m . 3 _______________

Sunday, October 30, 2016Consultations in Dermatopathology (Courses 400-408) ___x 1 .25 each _______________Oral Abstract Session 3 7:30 a .m . – 8:30 a .m . 1 _______________Short Course IV 8:45 a .m . – Noon 3 .25 _______________

Total Hours: _____________

Page 68: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

68 www.asdp.org/AM16 #ASDP2016

Notes

Page 69: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 69

Notes

Page 70: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

70 www.asdp.org/AM16 #ASDP2016

Notes

Page 71: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 71

Notes

Page 72: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

72 www.asdp.org/AM16 #ASDP2016

Notes

Page 73: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 73

Notes

Page 74: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

74 www.asdp.org/AM16 #ASDP2016

Notes

Page 75: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 75

Notes

Page 76: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of DermatopathologyThe American Society of Dermatopathology

76 www.asdp.org/AM16 #ASDP2016

Notes

Page 77: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 77

The American Society of Dermatopathology

Inde

x of F

acul

ty

Index

AAbbott, James J . . . . . . . . . . . . . . . . . . . . . 52Ali, Liaqat . . . . . . . . . . . . . . . . . . . . . . . . . . . 32André, Josette . . . . . . . . . . . . . . . . . . . . . . 41Argenyi, Zsolt B . . . . . . . . . . . . . . . . . . . . . . 58Aung, Phyu . . . . . . . . . . . . . . . . . . . . . . . . . 63

BBahrami, Armita . . . . . . . . . . . . . . . . . . . . 34Bandino, Justin P . . . . . . . . . . . . . . . . . . . . 43Barnhill, Raymond L . . . . . . . . . . . 34, 35, 56Bastian, Boris C . . . . . . . . . . . . . . . . . . . . . 35Berlingeri, Alma C . . . . . . . . . . . . . . . . . . . 63Berry, Ryan S . . . . . . . . . . . . . . . . . . . . . . . . 42Billings, Steven D . . . . . . . . . . . . . . 33, 57, 58Braswell, Diana . . . . . . . . . . . . . . . . . . . . . 30Bridges, Alina G . . . . . . . . . . . . . . . . . . . . . 58Brinster, Nooshin K . . . . . . . . . . . . . . . . . . 36Brown, Ryanne A . . . . . . . . . . . . . . . . . . . . 28Busam, Klaus J . . . . . . . . . . . . . . . . . . . . . . 34

CCampbell, Ryan . . . . . . . . . . . . . . . . . . . . . 29Cassarino, David S . . . . . . . . . . . . . . . . . . . 56Cheeney, Greg . . . . . . . . . . . . . . . . . . . . . . 36Chen, Pei-Ling . . . . . . . . . . . . . . . . . . . . . . 28Chen, Stephanie J .T . . . . . . . . . . . . . . . . . . 43Chen, Tiffany . . . . . . . . . . . . . . . . . . . . . . . 31Clarke, Loren E . . . . . . . . . . . . . . . . . . . . . . 53Cockerell, Clay J . . . . . . . . . . . . . . . . . . . . . 59Cohen, Jarish N . . . . . . . . . . . . . . . . . . . . . 36Cooper, Lynn D . . . . . . . . . . . . . . . . . . . . . . 57Coscarart, Aimee . . . . . . . . . . . . . . . . . . . . 31Cowper, Shawn E . . . . . . . . . . . . . . . . . . . . 60

DDeng, April C . . . . . . . . . . . . . . . . . . . . . . . . 63DiCaudo, David J . . . . . . . . . . . . . . 55, 58, 59Dickey, Brianne . . . . . . . . . . . . . . . . . . . . . 30Duncan, Lyn M . . . . . . . . . . . . . . . . 32, 54, 58

EElenitoba-Johsnon, Kojo . . . . . . . . . . . . 39Elston, Dirk M . . . . . . . . . . . . . 25, 45, 56, 59Emanuel, Patrick O . . . . . . . . . . . . . . . . . . 56

FFeasel, Patrick . . . . . . . . . . . . . . . . . . . . . . 36Fernandez-Pol, Sebastian . . . . . . . . . . . 27Ferringer, Tammie C . . . . . . . . . . . . . . 25, 54Fresco, Amber . . . . . . . . . . . . . . . . . . . . . . 31Fujimoto, Masakazu . . . . . . . . . . . . . . . . . 52Fung, Maxwell A . . . . . . . . . . . . . . . . . . 58, 59

GGardner, Jerad M . . . . . . . . . . . . . . . . . . . . 59Gerami, Pedram . . . . . . . . . . . . . . . . . 56, 59Ghosh, Toshi . . . . . . . . . . . . . . . . . . . . . . . . 36Goldberg, Lynne J . . . . . . . . . . . . . 57, 58, 60Golitz, Loren E . . . . . . . . . . . . . . . . . . . . . . . 56Green, Audrey . . . . . . . . . . . . . . . . . . . . . . 30Gru, Alejandro A . . . . . . . . . . . . . . . . . . . . . 48Guitart, Joan . . . . . . . . . . . . . . . . . . . . . . . 54

HHan, Jiali . . . . . . . . . . . . . . . . . . . . . . . . . . . 38Hedayat, Amin A . . . . . . . . . . . . . . . . . . . . . 30Hinds, Brian R . . . . . . . . . . . . . . . . . . . . . . . 37Hinshaw, Molly A . . . . . . . . . . . . . . . . . . . . 40Hoang, Mai P . . . . . . . . . . . . . . . . . . . . . 56, 57Hoon, Dave S . . . . . . . . . . . . . . . . . . . . . . . . 38Hsiao, Susan J . . . . . . . . . . . . . . . . . . . . . . . 37Hurley, M . Yadira . . . . . . . . . . . . . . . . . 25, 27

Page 78: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

The American Society of Dermatopathology

78 www.asdp.org/AM16 #ASDP2016

IIsales, Maria C . . . . . . . . . . . . . . . . . . . . . . . 30Ivan, Doina . . . . . . . . . . . . . . . . . . . . . . . . . 56

JJeter, Elaine K . . . . . . . . . . . . . . . . . . . . . . . 25Jordan, Richard C . . . . . . . . . . . . . . . . . . . 58

KKamino, Hideko . . . . . . . . . . . . . . . . . . . . . 57Karai, Laszlo J . . . . . . . . . . . . . . . . . . . . . . . 56Kempf, Werner . . . . . . . . . . . . . . . . . . . . . . 55Kim, Jinah . . . . . . . . . . . . . . . . . . . . 25, 54, 56Klimas, Natasha K . . . . . . . . . . . . . . . . . . . 30Knopp, Eleanor A . . . . . . . . . . . . . . . . . 59, 60Ko, Jennifer S . . . . . . . . . . . . . . . . . . . . . . . 48Kovarik, Carrie L . . . . . . . . . . . . . . . . . . . . . 63Kozel, Jessica A . . . . . . . . . . . . . . . . . . . . . 26Kwock, Jessica M . . . . . . . . . . . . . . . . . . . . 43

LLano, Ian Marie L . . . . . . . . . . . . . . . . . . . . 43Lazova, Rossitza . . . . . . . . . . . . . . . . . . . . 52LeBoit, Philip E . . . . . . . . . . . . . . . . . . . . . . 59Lee, Jonathon J . . . . . . . . . . . . . . . . . . . . . 27Lehman, Julia S . . . . . . . . . . . . . . . . . . . . . 52Lian, Christine G . . . . . . . . . . . . . . . . . . . . . 57Litzner, Brandon . . . . . . . . . . . . . . . . . . . . 26Liu, Vincent . . . . . . . . . . . . . . . . . . . . . . . . . 63Love, Nick R . . . . . . . . . . . . . . . . . . . . . . . . . 37Lowe, Lori . . . . . . . . . . . . . . . . . . . . . . . 32, 34

MMa, Sophia A . . . . . . . . . . . . . . . . . . . . . . . . 28Mauzo, Shakuntala H . . . . . . . . . . . . . . . . 28McCalmont, Timothy H . . . . . . . . . . . . . . 59Miller, Daniel D . . . . . . . . . . . . . . . . . . . . . . 59Mohammad, Mustafa M . . . . . . . . . . . . . . 29Moshiri, Ata . . . . . . . . . . . . . . . . . . . . . . . . . 31

NNapekoski, Karl M . . . . . . . . . . . . . . . . . . . 32Nawar, Nariman A . . . . . . . . . . . . . . . . . . . 31

OOllague, Jose E . . . . . . . . . . . . . . . . . . . . . . 42

PPatel, Anisha B . . . . . . . . . . . . . . . . . . . . . . 63Patel, Rajiv M . . . . . . . . . . . . . . . . . . 52, 57, 59Patel, Smita C . . . . . . . . . . . . . . . . . . . . . . . 27Peters, Sara B . . . . . . . . . . . . . . . . . . . . . . . 63Petronic-Rosic, Vesna . . . . . . . . . . . . . . . 56Piepkorn, Michael W . . . . . . . . . . . . . . . . . 34Pincus, Laura B . . . . . . . . . . . . . . . . . . . . . . 58Pradhan, Dinesh . . . . . . . . . . . . . . . . . . . . 31Pruitt, Laura Gray . . . . . . . . . . . . . . . . . . . 36Pulitzer, Melissa . . . . . . . . . . . 37, 38, 48, 59Puri, Puja K . . . . . . . . . . . . . . . . . . . . . . . . . 52

RRabkin, Michael S . . . . . . . . . . . . . . . . . . . . 33Rainwater, Yevgeniya B . . . . . . . . . . . . . . 42Rand, Andrew J . . . . . . . . . . . . . . . . . . . . . 43Rapini, Ronald P . . . . . . . . . . . . . . . . . . 62, 63Rieger, Kerri E . . . . . . . . . . . . . . . . . . . . . . . 63Robinson-Bostom, Leslie . . . . . . . . . . . . 29Robson, Alistair M . . . . . . . . . . . . . . . . . . . 55Rodic, Nemanja . . . . . . . . . . . . . . . . . . . . . 28Roy, Katherine . . . . . . . . . . . . . . . . . . . . . . 42Ruben, Beth S . . . . . . . . . . . . . 40, 41, 58, 59Rubin, Adam I . . . . . . . . . . . . . . . . . 40, 56, 58Ruiz De Luzuriaga, Arlene . . . . . . . . . . . . 63

SSangueza, Omar P . . . . . . . . . . . . . . . . . . . 57Scopetta, John . . . . . . . . . . . . . . . . . . . . . 43Selim, M . Angelica . . . . . . . . . . . . . . . . . . . 58Shalin, Sara . . . . . . . . . . . . . . . . . . . . . . . . . 42

Page 79: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at:

Inde

x of F

acul

ty

The American Society of Dermatopathology Meeting Program

#ASDP2016 www.asdp.org/AM16 79

Shanes, Elisheva . . . . . . . . . . . . . . . . . . . . 30Skipper, Daniel C . . . . . . . . . . . . . . . . . . . . 29Smith, Emily H . . . . . . . . . . . . . . . . . . . . . . 43Sperling, Leonard C . . . . . 48, 57, 59, 60, 61Sriharan, Aravindhan . . . . . . . . . . . . . . . . 43Stefanato, Catherine M . . . . . . . . . 58, 59, 60Subtil, Antonio . . . . . . . . . . . . . . . . . . . 54, 59Sundram, Uma N . . . . . . . . . . . . . . . . . . . . 26

TTan, Timothy . . . . . . . . . . . . . . . . . . . . . . . 30Taube, Janis M . . . . . . . . . . . . . . . . . . . 35, 63Tetzlaff, Michael . . . . . . . . . . . . . . . . . . . . . 52Thompson, Curtis T . . . . . . . . . . . . . . . . . . 40Torres-Cabala, Carlos . . . . . . . . . . . . . . . 48

UUberti, Georgina . . . . . . . . . . . . . . . . . . . . 31

VVidal, Claudia I . . . . . . . . . . . . . . . . . . . . . . 26

WWeiss, Sharon W . . . . . . . . . . . . . . . . . . . . . 47White, Thomas . . . . . . . . . . . . . . . . . . . . . . 38Wofford, Jay . . . . . . . . . . . . . . . . . . . . . . . . 43

YYaseen, Alae Abod . . . . . . . . . . . . . . . . . . . 28

ZZembowicz, Artur . . . . . . . . . . . . . . . . . . . 57

ISDP Glasgow 2017

XXXVIII Symposium of International Society of Dermatopathology

28 - 30 September 2017 | Glasgow | Scotland | UK

isdp2017.com | email: [email protected]

61774 BAD ISDP GLASGOW 2017 ADVERTv2.indd 1 21/09/2016 12:58

Page 80: ASDP · Based on SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. Available at: